¥È¥Ã¥×¥Ú¡¼¥¸¤Ø¤â¤É¤ë
¾ÉÎãÊó¹ð¤Øback

¤É¤³¤«¡Ê³¤³°¤«¤é¡©¡Ë¤Î¥¢¥Û¤¬ÊѤʥê¥ó¥¯¤ò¤Ï¤Ã¤Æ¤­¤Æ¤¤¤Þ¤¹¡£¤ª¤«¤·¤Ê¥ê¥ó¥¯¤Ï·è¤·¤Æ¥¯¥ê¥Ã¥¯¤·¤Ê¤¤¤Ç¤¯¤À¤µ¤¤¡£

ÀŲ¬ÉÂÍý°å²ñ Shizuoka Pathologist Seminar(SPS)¤ÎWhat's New

ÀŲ¬ÉÂÍý°å²ñ¤Î²ñ°÷¤Î¤«¤¿¤Çvirtual slide¤ò¤ß¤ë¤¿¤á¤ÎID, password¤¬É¬ÍפÊÊý¤Ï¥á¡¼¥ë¤òwikipathologica@gmail.com¤Þ¤Ç¤´Á÷ÉÕ¤¯¤À¤µ¤¤¡£ÀÞ¤êÊÖ¤·Ï¢Íí¤¤¤¿¤·¤Þ¤¹¡£

CONTENTS

 

ÀŲ¬ÉÂÍý°å²ñ¡¡Shizuoka Pathologist Seminar(SPS)

ÀŲ¬ÉÂÍý°å²ñ¤Ï4̾¤ÎÉÂÍý°å¤Ë¤è¤ê1976ǯ¤Ë·ëÀ®¤µ¤ì¤Æ°ÊÍè273²ó¤Î¾ÉÎ㸡Ƥ²ñ¤ò¹Ô¤Ã¤Æ¤¤¤Þ¤¹¡¥1985ǯ¤«¤é¤Ï´ØÅìÆîÉôÃ϶è¤ÎÉÂÍý°å¤È¶¦Æ±¤ÇSPS¾ëÆîÉÂÍý½¸Ã̲ñ¤ò³«ºÅ¤¹¤ë¤è¤¦¤Ë¤Ê¤ê¤Þ¤·¤¿¡¥¸½ºß¤Þ¤ÇÌó1480Îã¤Îŵ·¿Î㡤µ©¾¯Îã¤Î¸¡Æ¤¤ò¹Ô¤Ã¤Æ¤¤¤Þ¤¹¡¥

SPS-¾ëÆîÉÂÍý½¸Ã̲ñ¤Î¥Ú¡¼¥¸¤Ø

¡Ê·É¾Îά¡Ë

 
 

Âè279²ó¡¡ÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2020ǯ10·î2Æü(ÅÚ) 13:30-17:00 ÀŲ¬»ÔΩÀجɱ¡Åì´Û 11F¡¡C²ñµÄ¼¼ ½¸²ñ¡ÜWeb»²²Ã¤Ç³«ºÅ.

1.¡Ö¾®»ùÀÔ¿ñ¼ðáç¤Î£±Îã¡Ê£¶ºÐ½÷»ù¡Ë¡×--low grade neuroglial tumor of the spinal cord

ÇϾì Áï¡ÊÉ;¾°å²ÊÂç³Ø°å³ØÉôÉí°É±¡ ÉÂÍý¿ÇÃDzʡË

2.¡Ö°­À­½ê¸«¤òȼ¤¦ Tailgut cyst ¤Î£±Îã¡×--Tailgut cyst with focal adenocarcinoma in situ

¼¾åÌÀµª ¡ÊÀŲ¬¸©Î©ÀŲ¬Áí¹çɱ¡ ÉÂÍý¿ÇÃDzʡË

3.¡Ö¿¼ÉôÀÅÌ®·ìÀò/ÇÙºÉÀò¾É¤ò·Àµ¡¤Ëȯ¸«¤µ¤ì¤¿ÍñÁã¼ðáç¤Î£±Îã¡×-- endometrioid carcinoma G3.

ÇÏ¾ì ·ò¡¢ÂçÄͽٲ𡢿¹ ¹°¼ù¡¢¾®ß·µý»Ë¡ÊÉ;¾°åÎÅ¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡË

4.¡Ö°­À­ÆðÉô¼ðáç¤Î£±Îã¡Ê40ÂåÃËÀ­¡Ë¡×--epithelioid sarcoma

»°¥Ã°æºÌ²Ö¡¢Âç·î´²Ïº¡ÊÀ»ÎìÉ;¾É±¡ ÉÂÍý¿ÇÃDzʡË

5.¡Ö½ÑÁ°¤Ë IPMN ¤òµ¿¤ï¤ì¤Æ¤¤¤¿¿»½áÀ­ç¹´É´â¤Î£±¼ê½ÑÎã¡×--IPMN, hepatobilliary type

»³Ìî»°µª¡ÊÀŲ¬°åÎÅ¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡË

6.¡ÖÄÁ¤·¤¤¸¶°ø¶Ý¤¬Æ±Äꤵ¤ì¤¿´¶À÷À­Æ°Ì®áî¤Î£±Îã¡×aneurythm with Hericobacter cinaedi infection

°ÂÅÄÏÂÀ¤£±¡Ë¡¤¹ÃÅĸ­¼£1¡Ë¡¤äëÅÄÏÂÈþ2¡Ë, Äé ´²3)

(1)Æ£»Þ»ÔΩÁí¹çɱ¡ ÉÂÍý¿ÇÃDzʡ¢£²)Ʊ ÈùÀ¸Êª¸¡ºº¡¢3)¤Ä¤Ä¤ßÉÂÍý¿ÇÃÇ²Ê ¡¡¡¡ ¥¯¥ê¥Ë¥Ã¥¯)

7.¡ÖÉ¡¹Ð¼ðáç¤Î£±Îã¡Ê30Âå½÷À­¡Ë¡×--HPV-related multiphenotypic sinonasal carcinoma(HMSC)

ÇϾì Áï¡ÊÉ;¾°å²ÊÂç³Ø°å³ØÉôÉí°É±¡ ÉÂÍý¿ÇÃDzʡË

 

Âè278²ó¡¡ÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2020ǯ8·îÆü(ÅÚ) 13:30-17:00 ÀŲ¬»ÔΩÀجɱ¡Åì´Û 11F¡¡C²ñµÄ¼¼¤Ç½¸²ñ¡ÜWeb»²²Ã¤Ç¹Ô¤¦.

 

Âè277²ó¡¡ÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2020ǯ2·î8Æü(ÅÚ) 13:30-17:00 ÀŲ¬»ÔΩÀجɱ¡Åì´Û 11F¡¡C²ñµÄ¼¼

1.¡ÖÀèÅ·À­ÇßÆÇ¤Î1Îã¡×

Éͺꡡ˭¡ÊÀŲ¬¸©Î©¤³¤É¤âɱ¡ ÉÂÍý¿ÇÃDzʡË

2.¡Ö¥¹¥Ë¥Á¥Ë¥ÖÅêÍ¿¸å¤Ë¼ê½Ñ¤µ¤ì¤¿±¦¿Õ¼ðáç¤Î1Îã¡×--Fumalate hydratase-deficient RCC

ĹÁÒ Í¥²Ö¡ÊÉ;¾°å²ÊÂç³ØÉí°É±¡ ÉÂÍý¿ÇÃDzʡË

3.¡ÖAFP»ºÀ¸¤ò¼¨¤·¤¿»ÒµÜðô´â¤Î2¾ÉÎã¡×--ÂÛ»ù¾Ã²½´ÉÎà»÷ÁÈ¿¥Áü¤òÄ褷¤¿AFP»ºÀ¸Á£´â

²ÏÅÄ ÂîÌé¡ÊÀŲ¬¸©Î©¤¬¤ó¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡË

6.¡Öpulmonary tumor throbotic microangiopathy(PTTM)¤Î°ì˶¸¡Îã¡×

ȬÌÚ½ÕÆà, ´ä²¼¼÷½¨¡ÊÉ;¾°å²ÊÂç³Ø ºÆÀ¸´¶À÷ÉÂÍý³Ø¹ÖºÂ¡Ë

5.¡Ö²È²À­½¬´·À­Î®»º (33ºÐ ½÷À­)¡×

°ÂÅÄÏÂÀ¤¡ÊÆ£»Þ»ÔΩÁí¹çɱ¡ ÉÂÍý¿ÇÃDzʡË

6.¡ÖBlastic plasmacytoid dendritic cell neoplasm¤Î2Îã¡×

¼¾åÌÀµª¡ÊÀŲ¬»ÔΩÀجɱ¡ ÉÂÍý¿ÇÃDzʡË

7.¡ÖÌȱ֥Á¥§¥Ã¥¯¥Ý¥¤¥ó¥ÈÁ˳²ºÞ¤Ë¤è¤ë´Î¾ã³²¤òǧ¤á¤¿1Îã¡×--nivolmab-associated severe hepatic injury

ȬÌÚ½ÕÆà, ¿·°æ°ì¼é, ÎëÌÚÀ¿(ÀŲ¬¸©Î©Áí¹çɱ¡ ÉÂÍý¿ÇÃDzÊ)

8.¡Ö¿×®¿ÇÃǤ˴ÕÊ̤òÍפ·¤¿ÇÙ¼ðáç¤Î1Îã¡×--ciliated muconodular papillary tumor (CMPT)

ÅÚÅÄ ¹§¡ÊÉ;¾°å²ÊÂç³ØÉí°É±¡ ÉÂÍý¿ÇÃDzʡË

²ñ½ªÎ»¸å¡¡¤Ò¤³¤Í¤Çº©¿Æ²ñ.

 

Âè276²ó¡¡ÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2019ǯ8·î31Æü(ÅÚ) 13:30-17:00 ÀŲ¬»ÔΩÀجɱ¡Åì´Û 11F¡¡C²ñµÄ¼¼

1.¡Ö´Î¼ðáî¤Î1Îã¡×

¿å¾åÏÂÉס¤ÎëÌÚĬ¿Í¡¤ÂçÀ¾°ìÊ¿¡¤Ã«²¬½ñɧ¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡ ÉÂÍý¿ÇÃDzʡË

2.¡ÖÃÀ´É¼ðáçÀò¤òȼ¤¦Å¾°ÜÀ­´Î¼ðáç¤â¤·¤¯¤Ï¸¶È¯À­´Î´â¤¬µ¿¤ï¤ì¤¿´Î¼ðáç¤Î£±Îã¡×

»³Ìî»°µª¡ÊÀŲ¬°åÎÅ¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡË

3.¡Öç¹¼ðáç¤Î°ìÎã¡×

ȬÌÚ½ÕÆà¡¤Â¼¾¾ ºÌ¡¤ÎëÌÚ À¿¡¤¿·°æ°ì¼é¡¤»ûÅÄÃé»Ë¡ÊÀŲ¬¸©Î©Áí¹çɱ¡ ÉÂÍý¿ÇÃDzʡË

4.¡Ö´ããݲ¼¿À·Ð¼ðáî¤Î£±Îã¡×

¼¾åÌÀµª¡ÊÀŲ¬»ÔΩÀجɱ¡ ÉÂÍý¿ÇÃDzʡË

5.¡Ö¿ÇÃǤޤǤË2¤«·î¤òÍפ·¤¿Ç߯ÇÀ­°ß±ê¤Î1Îã¡×

°ÂÅÄÏÂÀ¤¡ÊÆ£»Þ»ÔΩÁí¹çɱ¡ ÉÂÍý¿ÇÃDzʡË

6.¡Ö¤Þ¤ì¤ÊÂçIJ¥Ý¥ê¡¼¥×¤Î1Îã¡×

¾®Ã«·òÂÀϺ¡¢µÌ½¼¹°¡¢¾®¿ù°Ë»°Éס¢Äé ´²¡Ê»ÔΩÅçÅÄ»Ô̱ɱ¡ ÉÂÍý¿ÇÃDzʡË

7.¡Ö¤Þ¤ì¤ÊÂçIJ´â¤Î1Îã¡×

µÌ ½¼¹°£±¡Ë¡¤°ëÌîÃéÂ磲¡Ë¡¤Äé ´²£±,£³¡Ë¡Ê£±¡Ë»ÔΩÅçÅÄ»Ô̱ɱ¡ ÉÂÍý¿ÇÃDzʡ¢£²¡ËƱ ³°²Ê¡¢£³¡Ë¤Ä¤Ä¤ßÉÂÍýÁêÃ̽ê¡Ë

ÆÃÊֱ̹é¡ÖÄÉÅé¡¡¼¼¡¡ÇîÇ·ÀèÀ¸¤ò¼Å¤ó¤Ç¡×

¾®¿ù°Ë»°ÉסÊÉ;¾°å²ÊÂç³Ø°å³ØÉôºÆÀ¸¡¦´¶À÷ÉÂÍý³Ø¹ÖºÂ¡Ë

 

Âè275²ó¡¡ÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2019ǯ6·î22Æü(ÅÚ) 13:30-17:00 ÀŲ¬»ÔΩÀجɱ¡Åì´Û 11F¡¡C²ñµÄ¼¼

1.¡ÖÍñÁã seromucinous borderline tumor ¤Ë¹çÊ»¤·¤¿ leiomyomatosis in pelvic lymph ¡¡node¡×--Leiomyomatosis in the pelvic lymph nodes complicated with ovarian seroumucinous borderline tumor

¹¾²Ïͦ¼ù¡ÊÀŲ¬»ÔΩÀجɱ¡ ÉÂÍý¿ÇÃDzʡË

2.¡Ö²èÁüŪ¤Ë¤âÁÈ¿¥³ØÅª¤Ë¤â¿ÇÃǤ¬ÍưפǤʤ«¤Ã¤¿»ÒµÜÉÂÊÑ¡×--Adenomyoma of the uterus

¼¾¾ ºÌ¡¤ÎëÌÚ À¿¡¤Á𿼸ø½¨¡¤¿·°æ°ì¼é¡¤»ûÅÄÃé»Ë¡ÊÀŲ¬¸©Î©Áí¹çɱ¡ ÉÂÍý¿ÇÃDzʡË

3.¡Ö°ßÇ´Ëì²¼ÉÂÊѤÎ1Îã¡×--Eosinophilic granuloma associated with chronic anisakiasis

¿å¾åÏÂÉס¤ÂçÀ¾°ìÊ¿¡¤ÎëÌÚĬ¿Í¡¤Ã«²¬½ñɧ¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡ ÉÂÍý¿ÇÃDzʡË

4.¡ÖÅüǢɴµ¼Ô¤ËȯÀ¸¤·¤¿Ê¢Éô¼ðáî¤Î1Îã¡×--Insulin ball; iatrogenic localized insulin-derived amyloidosis

µÌ ½¼¹°¡¤¾®Ã«·òÂÀϺ¡¤Äé ´²¡Ê»ÔΩÅçÅÄ»Ô̱ɱ¡ ÉÂÍý¿ÇÃDzʡË

5.¡ÖÆÍÁ³»àÎã¡Ê¥¤¥ó¥Õ¥ë¥¨¥ó¥¶´¶À÷¡Ë£¸ºÐ ÃË»ù¡×--Sudden death associated with Influenza B virus infection

ÉÍùõ Ë­¡ÊÀŲ¬¸©Î©¤³¤É¤âɱ¡ ÉÂÍý²Ê¡Ë

6.¡Öç¯æù´â¤¬µ¿¤ï¤ì·ÐÇ¢Æ»Åªç¯æù¼ðáçÀÚ½ü½Ñ¤¬»Ü¹Ô¤µ¤ì¤¿°ìÎã¡×--Urinary schistosomiasis (bilharzia)

ÂçÀ¾°ìÊ¿1,2¡¤ÎëÌÚĬ¿Í1¡¤¿å¾åÏÂÉ×1¡¤¿ú¼½Õɧ2¡¤Ã«²¬½ñɧ1¡Ê1ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¤2É;¾°å²ÊÂç³Ø¼ðáçÉÂÍý³Ø¹ÖºÂ¡Ë

7.¡Öº¸Àå¼ðáç¤Î°ìÎã¡×--Basaloid squamous cell carcinoma of the left side of the tongue

Á𿼸ø½¨¡¤Â¼¾¾ ºÌ¡¤ÎëÌÚ À¿¡¤¿·°æ°ì¼é¡¤»ûÅÄÃé»Ë ¡ÊÀŲ¬¸©Î©Áí¹çɱ¡ ÉÂÍý¿ÇÃDzʡË

8.¡ÖÇżïÀ­ÂÓ¾õá׿¾¤Ë¤è¤ë·à¾É´Î±ê¤¬µ¿¤ï¤ì¤¿£±Îã¡×--Systemic varicella-zoster virus infection after chemotherapy against post-transplant lymphoproliferative disorder

ÀÐÀî Îå¡ÊÉ;¾°å²ÊÂç³ØÉí°É±¡ ÉÂÍý¿ÇÃDzʡË

 

Âè273²ó ÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2019ǯ2·î9Æü(ÅÚ) 13:30-17:00 ÀŲ¬»Ô, ÀŲ¬»ÔΩɱ¡À¾´Û12F, ¹ÖƲ

1. ·ëÀáÀ­¹Å²½¾Éµ¿¤¤¾ÉÎã¤Î¿Õ¼ðáç¤Î1Îã¡¡39ºÐ½÷À­--Renal cell carcinoma with smooth muscle (or leiomyomatous) stroma(WHO̤¼ýºÜ)

Äŵװ湨·Ã¤Û¤«¡¡É;¾°å²ÊÂç³ØÉí°É±¡ÉÂÍý¿ÇÃDzÊ

2. ±ê¾ÉÀ­À®Ê¬¤òȼ¤¦´Î·ì´É¶Ú»éËüð¤Î°ìÎã¡¡50ºÐÃËÀ­--Hepatic angiomyolipoma with an inflammatory component

ÎëÌÚĬ¿Í¤Û¤«¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzÊ

3. ³°±¢ÉôÈé²¼¼ðáç¤Î°ìÎã¡Ê¤½¤Î2)¡¡45ºÐ½÷À­--Cellular angiofibroma (?)

ÀÐÀîÎå¤Û¤«¡¡É;¾°åÂçÉí°É±¡ÉÂÍý¿ÇÃDzʡ¢Ë­¶¶»Ô̱ɱ¡ÉÂÍý¿ÇÃDzÊ

4. ¹­ÈϤʿ»½á¤ò¼¨¤·¤¿Æý´â¤Î°ìÎã 63ºÐ½÷À­--Acinic cell carcinoma of the breast

¿ùÌîδ¡¡ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzÊ

5. Charcot-Leyden ·ë¾½¤òȼ¤Ã¤¿¹¥»ÀÀ­Æù²ê¼ð¤Î2Î㤪¤è¤Óµ¤´É»ÙÓé¤Î1Îã--extracellular trap cell death

ÉͺêË­¡¡ÀŲ¬¸©Î©¤³¤É¤âɱ¡. ÉÂÍý²Ê

6. ±¦Â¦Æ¬ÉôÈéÉæ¼ðáç 83ºÐ½÷À­--primary cutaneous anaplastic large cell lymphoma, ALK-negative.

¾®¿ù°Ë»°Éס¡É;¾°å²ÊÂç³ØºÆÀ¸´¶À÷ÉÂÍý³Ø¹ÖºÂ

7. Ê¢¹ÐÆâ¼ðáç¤Î°ìÎã 20ºÐÂå½÷À­--yolk sac tumor of the peritoneum

ȬÌÚ½ÕºÚ¤Û¤«¡¡É;¾°å²ÊÂç³ØºÆÀ¸´¶À÷ÉÂÍý³Ø¹ÖºÂ, ÀŲ¬¸©Î©Áí¹çɱ¡ÉÂÍý¿ÇÃDzÊ

8. KITÌîÀ¸·¿GIST¤Î°ìÎã¡¡69ºÐÃËÀ­-- Carney-Stratakis syndrome (GIST and paraganglioma, SDHB-mutant)

ÇϾìÁï¡¡É;¾°åÂçÉí°É±¡ÉÂÍý¿ÇÃDzÊ

9. Ãæ°öƬ¼ðáç¤Î°ì¼ê½ÑÎã¡¡56ºÐÃËÀ­--HPV-unrelated multiphenotypic carcinoma (?)

Á𿼸ø½¨¡¡ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzÊ

 

Âè272²ó ÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2018ǯ12·î8Æü(ÅÚ) 13:30-17:00 ÀŲ¬»Ô, ÀŲ¬»ÔΩɱ¡À¾´Û12F, ¹ÖƲ

1. ¡ÖÁÈ¿¥·¿¤¬ÌäÂê¤È¤Ê¤Ã¤¿¼ãǯÀ­»ÒµÜÂδâ¤Î°ìÎã¡×20ºÐÂå½÷À­--Endometrioid carcinoma with corded and hyalinized pattern

²ÏÅÄÂîÌé¡¡ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzÊ

2. ¡ÖÆýÁ£¼ðáç¤Î°ìÎã¡×78ºÐ½÷À­--microglandular adenosis with carcinoma

ÂçÄͽٲð¤Û¤«¡¡É;¾°åÎÅ¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzÊ

3. ¡Ö³°±¢ÉôÈé²¼¼ðáç¤Î°ìÎã¡×45ºÐ½÷À­-- myoepithelioma

ÀÐÀîÎå¤Û¤«¡¡É;¾°åÂçÉí°É±¡ÉÂÍý¿ÇÃDzʡ¢Ë­¶¶»Ô̱ɱ¡ÉÂÍý¿ÇÃDzÊ

4. ¡Ö¥¿¥ó¥Ñ¥¯Ï³½ÐÀ­°ßIJ¾É¤Î°ìÎã¡× 50ºÐÂåÃËÀ­---Strongyloidiasis (ʵÀþÃî¾É)

Ìܹõ»Ë¿¥¡¡É;¾°å²ÊÂç³ØºÆÀ¸´¶À÷ÉÂÍý³Ø¹ÖºÂ¡¢Ë­Àî»Ô̱ɱ¡ÉÂÍý¿ÇÃDzÊ

5.¡ÖÂçÆ°Ì®²òÎ¥¤ÎÉÂÍý¡×---Aortic dissection

¹¾²Ïͦ¼ù¡¢¿¹ÌÚÍø¾¼¡ÊÀŲ¬»ÔΩÀجɱ¡ ÉÂÍý¿ÇÃDzÊ

6. ¡Ö½ÑÁ°¿ÇÃÇ¤ËÆñ½Â¤·¤¿½½Æó»ØÄ²°ß·¿Á£´â¡×63ºÐÃËÀ­--Duodenal adenocarcinoma, gastric type

¹¾²Ïͦ¼ù ÀŲ¬»ÔΩÀجɱ¡¡¡ÉÂÍý¿ÇÃDzÊ

 

¥«¥ó¥Õ¥¡¥ì¥ó¥¹½ªÎ»¸å¡¡ËºÇ¯²ñ@ ¡Ö¤Ò¤³¤Í¡×

 

Âè271²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

Âè271²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ï SPS-¾ëÆîÉÂÍý¹çƱº©Ã̲ñ¤Ë¤Ê¤ê¤Þ¤¹

2018ǯ10·î6Æü¡ÊÅÚ¡Ë ÅìµþÅÔÉÊÀî¶è´ú¤ÎÂæ ¾¼ÏÂÂç³ØÉ±¡Î×¾²¹ÖƲ

 

Âè270²ó ÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2018ǯ8·î25Æü(ÅÚ) 13:30-17:00 ÀŲ¬»Ô, ÀŲ¬»ÔΩɱ¡Åì´Û11F, C²ñµÄ¼¼

1.¡Ö°ß¼ðáç¤Î°ìÎã¡×---Gastric adenocarcinoma of funds gland type, chief cell predominant type

ȬÌÚ½ÕÆà¡¢¹â¶¶ÀÄ»ÖϺ¡¢¾®Àî¡¡Çî¡ÊÀ»Îì»°Êý¸¶É±¡ ÉÂÍý¿ÇÃDzʡË

2.¡ÖIJÊĺɤò·«¤êÊÖ¤¹£±Îã¡×---Mesenteric phlebosclerosis

ÂçÄͽٲ𡢿¹ ¹°¼ù¡¢¾®ß·µý»Ë¡ÊÉ;¾°åÎÅ¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡË

3.¡Ö¥¢¥ë¥³¡¼¥ëÀ­´Î¹ÅÊѤˤߤé¤ì¤¿´Î·ëÀáÀ­ÉÂÊѤΣ±Îã¡×---Serum amyloid A-positive hepatocellular neoplasm/nodule arising in alcoholic liver cirrhosis

Äŵװ湨·Ã¡ÊÉ;¾°å²ÊÂç³ØÉí°É±¡ ÉÂÍý¿ÇÃDzʡË

4.¡ÖSerous endometrial intraepithelial carcinoma ¤Î°ìÎã¡×---Serous endometrial intraepithelial carcinoma

ÎëÌÚĬ¿Í¡¢ÂçÀ¾°ìÊ¿¡¢Ã«²¬½ñɧ¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡ ÉÂÍý¿ÇÃDzʡË

5.¡ÖÁá´ü°ß´â¤Î³ÔÀ¶¥ê¥ó¥ÑÀá¤Çȯ¸«¤µ¤ì¤¿¶öȯÉÂÊѤΣ±Îã¡×---Incidental well differentiated liposarcoma around the dissected lymph nodes #4sb

ÇϾ졡Áï¡ÊÉ;¾°å²ÊÂç³ØÉí°É±¡ ÉÂÍý¿ÇÃDzʡË

6.¡ÖǾ¼ðáç(DNT), 11ºÐ ÃË»ù¡×---Dysembrioplastic neuroepithelial tumor (DNT), non-specific and diffuse form

Éͺꡡ˭¡ÊÀŲ¬¸©Î©¤³¤É¤âɱ¡ ÉÂÍý²Ê¡Ë

7.¡Ö½Ä³Ö¼ðáç¤Î£±Îã¡×---Thymic MALT lymphoma

¿å¾åÏÂÉס¢Âç·î´²Ïº¡¢¿·°æµÁʸ¡¢¾®ÎÓ¡¡´²¡ÊÀ»ÎìÉ;¾É±¡ ÉÂÍý¿ÇÃDzʡË

8.¡Ö¹Ã¾õÁ£¼ðáç¤Î°ìÎã¡×---TTF-1-positive Thymoma, type AB, arising from ectopic thymus

ĹÁÒÍ¥²Ö¡¢ÅÚÅÄ¡¡¹§¡ÊÉ;¾°å²ÊÂç³ØÉí°É±¡ ÉÂÍý¿ÇÃDzʡË

9.¡ÖƬ³¸Äì Focal Haematopoietic Hyperplasia ¤Î°ìÎã¡×---Focal hematopoietic hyperplasia (Reconversion from yellow to red marrow) of the calvarium

¹¾²Ïͦ¼ù¡¢¿¹ÌÚÍø¾¼¡ÊÀŲ¬»ÔΩÀجɱ¡ ÉÂÍý¿ÇÃDzʡË

¡ÚÏ¢Íí»ö¹à¡Û

1.2018ǯÅÙ Âè1²óÉÂÍýÀìÌç°åÍÜÀ®¸¦½¤²ñ¡ÊÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¼çºÅ¡Ë ¡¡Æü»þ¡§ 2018ǯ9·î8Æü¡ÊÅÚ¡Ë13¡§00¡Ý16¡§20 ¡¡²ñ¾ì¡§ ¥µ¥ó¥Ñ¥ì¥¹¥Û¥Æ¥ë¡ÊÀŲ¬»Ô¡Ë

2.Ê¿À®30ǯ ¾ëÆîÉÂÍý-SPS ¹çƱº©Ã̲ñ ¡¡Æü»þ¡§10·î£¶Æü¡ÊÅÚÍËÆü¡Ë13¡§30?¡Ê¼õÉÕ13¡§00¡Ë ¡¡²ñ¾ì¡§¾¼ÏÂÂç³Ø¡Ê´ú¤ÎÂæ¡ËÎ×¾²¹ÖƲ¡ÊÆþ±¡ÅïÃϲ¼£±³¬¡Ë

²ñ½ªÎ»¸å¡¡¤Ò¤³¤Í¤ÇǼÎòñ

Âè269²ó ÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2018ǯ6·î9Æü(ÅÚ) 13:30-17:00 ÀŲ¬»Ô, ÀŲ¬»ÔΩɱ¡Åì´Û11F, C²ñµÄ¼¼

1. ¡ÖÊ¢Ëì¼ðáç¤Î1Îã¡×---undifferenciated (pleomorphic) sarcoma/ dedifferentiated liposarcoma

ÀÐÀî¡¡Îå¡¡É;¾°å²ÊÂç³ØÉհɱ¡ ÉÂÍý¿ÇÃDzÊ

2. ¡ÖǾ¼ðáç¤Î°ìÎã¡×--subependymoma with intraventricular hemorrhage ¾ÉÎã¤Î¥Ú¡¼¥¸

ȬÌÚ½ÕÆà¾, À»Îì»°Êý¸¶É±¡¡¡ÉÂÍý¿ÇÃDzÊ

3.¡¡¡Ö¿©Æ»¼ðáç¤Î°ìÎã¡×--Lymphoepithelial carcinoma of the esophagus

¿å¾åÏÂÉפۤ«¡¡À»ÎìÉ;¾É±¡ÉÂÍý¿ÇÃDzÊ

4.¡¡¡Ö¹Ã¾õÁ£´â¤Î°ì¼ê½ÑÎã¡×--Warthin-like papillary carcinoma+ papillary carcinoma

Á𿼸ø½¨¡¡ÀŲ¬¸©Î©¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzÊ

5.¡¡¡ÖßÉ˦À­¥ê¥ó¥Ñ¼ð? ¥Þ¥¸¤Ã¤¹¤«.- Follicular lymphoma with diffuse growth pattern¤Î2¾ÉÎã¡×

벬½ñɧ¤Û¤«¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzÊ

6.¡¡¡Ö¿Õ¡¸¶È¯ Ewing sarcoma/ primitive neuroectodermal tumor¤Î°ìÎã¡×

ÂçÀ¾°ìÊ¿¤Û¤«¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzÊ

7.¡¡¡Ö´Îǹ˦À­¼ðáç¤Î°ìÎã¡×--undifferentiated sarcoma(embryonal sarcoma) of the liver

ĹÁÒÍ¥²Ö¤Û¤«¡¡É;¾°å²ÊÂç³ØÉհɱ¡ ÉÂÍý¿ÇÃDzÊ, Ë­¶¶»Ô̱ɱ¡ÉÂÍý¿ÇÃDzÊ

 

Âè268²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2018ǯ4·î7Æü(ÅÚ) 13:30-17:00 ÀŲ¬»Ô, ÀŲ¬»ÔΩɱ¡Åì´Û11F, C²ñµÄ¼¼

1.¡Ö°ßÇ´Ëì²¼¼ðáç¤Î£±Îã¡×Gastrointestinal Glomus tumor

ÇϾ졡Áï É;¾°å²ÊÂç³ØÉí°É±¡ ÉÂÍý¿ÇÃDzÊ

2.¡ÖLow grade neuroendocrine tumor ¤¬µ¿¤ï¤ì¤¿»ÒµÜ¼ðáç¤Î°ìÎã¡×¡Ëuterine tumor resembling ovarian sex-cord tumor

¼¾¾¡¡ºÌ ÀŲ¬¸©Î©Áí¹çɱ¡ ÉÂÍý¿ÇÃDzÊ-->¤´¸ü°Õ¤Ë¤è¤ê,ȯɽ¥¹¥é¥¤¥ÉPDF, ¤ª¤è¤ÓVirtual slide »²¾È²Äǽ¤Ç¤¹.

3.¡ÖÊ¢ÊÉ·ëÀá¤Î1Îã¡×eosinophilic cellulitis due to Paragonimiasis (Paragoinimus skrjabini), abdominal wall

ÂçÄͽٲ𡢿¹ ¹°¼ù¡¢¾®ß·µý»Ë¡ÊÉ;¾°åÎÅ¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡË

4.¡Ö´â¼ðÀ®Ê¬¤È¤·¤ÆÛùÍ»²ò·¿Ù¨Ê¿¾åÈé´â¤ÈÂñÕÁ£Æ³´É´â¤¬È¯À¸¤·¤¿Â¿·ÁÁ£¼ðͳÍè´â¤Î°ìÎã¡×Carinoma ex pleomorphic adenoma (CXPA) composed of both acantholytic squamous cell carcinoma (ASCC) and salivary duct carcinoma (SDC) components

Á𿼸ø½¨¡ÊÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡË

5.¡ÖÆÍÁ³»à¤·¤¿Ã˻Ҿ®³ØÀ¸¤Î£±Ë¶¸¡Îã¡×¡¡Arrhythmogenic right ventricular cardiomyopathy (ARVC)

¿å¾åÏÂÉס¢Âç·î´²Ïº¡¢¿·°æµÁʸ¡¢¾®ÎÓ¡¡´²¡ÊÀ»ÎìÉ;¾É±¡ ¡¡¡¡ÉÂÍý¿ÇÃDzʡË

6.¡ÖIgD multiple myeloma ¤Î°ìÎã¡×CD20-positive IgD myeloma

¹â¶¶¡¡±û, ÂçÀ¾°ìÊ¿, ÎëÌÚĬ¿Í, 벬½ñɧ¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡ ÉÂÍý¿ÇÃDzÊ)--->ȯɽ¥¹¥é¥¤¥ÉPDF¤¬»²¾È²Äǽ¤Ç¤¹.

7.¡Ö°ß´âÆù¼ð¤Î°ìÎã¡× Carcinosarcoma of the stomach; AFP-producing adenocarcinoma with enteroblastic differentiation and sarcomatoid change (AFP, GPC3, SALL4, Claudin-6¤¬ÂÛ»ùÀ®Ê¬¤ÎÌÈÀ÷¤ËÍ­ÍÑ)

Ìܹõ»Ë¿¥¡ÊÉ;¾°å²ÊÂç³Ø ºÆÀ¸¡¦´¶À÷ÉÂÍý³Ø¹ÖºÂ¡Ë

8.¡Ö¿´º¸Ë¼Æâ¼ðáç¤Î£±Îã¡×Cardiac osteosarcoma of the left atrium; extraskeletal osteosarcoma

ÀÐÀî¡¡Îå¡ÊÉ;¾°å²ÊÂç³ØÉí°É±¡ ÉÂÍý¿ÇÃDzʡË

 
  • SPS ¿·¥á¥ó¥Ð¡¼¾Ò²ð
  • ¡ÖUSCAP 2018 Annual Meeting ¤Ë»²²Ã¤·¤Æ¡×

    ȬÌÚ½ÕÆà¡ÊÀ»Îì»°Êý¸¶É±¡ ÉÂÍý¿ÇÃDzʡË

  • ¡ÖIARC ÂÚºßÃæÊó¹ð Short Report from International Agency for Research on Cancer¡×

    ÅÏî´Îï»Ò¡ÊSenior visiting scientist,IARC/¹ñΩ¤¬¤ó¥»¥ó¥¿¡¼¡Ë¥¹¥é¥¤¥ÉÊó¹ð

 

Âè267²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2018ǯ1·î27Æü(ÅÚ) 13:30-17:00 ÀŲ¬»Ô, ÀŲ¬»ÔΩɱ¡À¾´Û11FÂè°ì²ñµÄ¼¼

1. Ž¢¥¹¥Æ¥í¥¤¥É¼£ÎŸå¤Î¶»Á£¼ðáç¤Î1Î㎣¡¡thymoma

ÀÐÀîÎå É;¾°å²ÊÂç³ØÉí°É±¡¡¡ÉÂÍý¿ÇÃDzÊ

2. Ž¢½ÑÃæ¿×®¿ÇÃǤ¬º¤Æñ¤Ç¤¢¤Ã¤¿ÇÙ¼ðáç¤Î1Î㎣¡¡PEComa of the lung

ȬÌÚ½ÕÆà¤Û¤«¡¡À»Îì»°Êý¸¶É±¡¡¡ÉÂÍý¿ÇÃDzÊ

3. Ž¢´ÎÆâÃÀ´É¼ðáç¤Î1Î㎣¡¡IPBN

ÂçÄͽٲð¤Û¤«¡¡É;¾°åÎÅ¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzÊ

4. Ž¢¿ÇÃǤ˶ìθ¤·¤¿ÇÙ·ëÀáÀ­ÉÂÊѤÎ1Î㎣ sarcomatoid mesothelioma

²ÏÅÄÂîÌé¤Û¤«¡¡ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzÊ

5. Ž¢°ßÀ¸¸¡¤«¤é¿»½áÀ­¾®Íմ⤬¸¡½Ð¤µ¤ì¤¿3Î㎣¡¡lobular carcinoma of the breast metastasized to the stomach, report of three cases.

¹¾²Ïͦ¼ù¤Û¤«¡¡ÀŲ¬»ÔΩÀجɱ¡¡¡ÉÂÍý¿ÇÃDzÊ

6. Ž¢²¼³Ü¥ê¥ó¥ÑÀá¼ðáç¤Î1Î㎣¡¡blastic plasmacytoid dendritic cell neoplasum

¾®¿ù°Ë»°Éס¡É;¾°å²ÊÂç³ØºÆÀ¸¡¦´¶À÷ÉÂÍý³Ø¹ÖºÂ

7. Ž¢Ç®Ãæ¾É¤Î1˶¸¡Î㎣¡¡

ĹÁÒÍ¥²Ö¡¡É;¾°å²ÊÂç³ØÉí°É±¡¡¡ÉÂÍý¿ÇÃDzÊ

²ñ½ªÎ»¸å¤Ë¡¡Ž¢¤Ò¤³¤ÍŽ£¤Ë¤ª¤¤¤Æ¿·Ç¯²ñ

 

Âè266²óÀŲ¬ÉÂÍý°å²ñ(SPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹)

Âè266²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ï SPS-¾ëÆîÉÂÍý¹çƱº©Ã̲ñ¤Ë¤Ê¤ê¤Þ¤¹

2017ǯ11·î11Æü¡ÊÅÚ¡Ë¡¡ÀŲ¬¸©»°Åç»Ô »°Åç»Ôʸ²½²ñ´ÛÂè2²ñµÄ¼¼

 

Âè265²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2017ǯ8·î26Æü(ÅÚ) ÀŲ¬»Ô, ÀŲ¬»ÔΩɱ¡Åì´Û11³¬C²ñµÄ¼¼

1.¡ÖÆñ¼£À­²¼Î¡¤Î£±Îã¡×-- ¥é¥ó¥Ö¥ëÊÜÌÓÀþÃî´¶À÷¾É/ ¾®Ä²

Äŵװ湨·Ã¤Û¤«¡ÊÉ;¾°å²ÊÂç³Ø ÉÂÍý¿ÇÃDzʡË

2.¡Ö²¼ÉôÃÀ´É¼ðáç¤Î1Îã¡×--undifferentiated carcinoma with osteoclast-like giant cells, bile duct

ĹÁÒÍ¥²Ö¤Û¤«¡ÊÉ;¾°å²ÊÂç³ØÉí°É±¡ÉÂÍý¿ÇÃDzÊ--> CHUBU1334¤Ïç¹Â¡¤Î¾ÉÎã

3.¡ÖCrohnɤǾ®Ä²ÀÚ½ü¤·¤¿1Îã¡×-- poorly diff. adenocarcinoma arising in inflammatory fibroid polyp of the patient having Chron disease

ÂçÄͽٲð¤Û¤«¡ÊÉ;¾°åÎÅ¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡË

4.¡Ö44ºÐ½÷À­¤ÎǢƻ¼ðáç¡×--Clear cell adenocarcinoma of urethra in woman

°ËÆ£°ÊÃÎûú(ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzʡË

5.¡Öž°ÜÀ­ÇÙ¼ðáç¤Î°ìÎã¡×---ameloblastoma metastasized to the lung

ÎëÌÚĬ¿Í¤Û¤«¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡ ÉÂÍý¿ÇÃDzʡË

6.¡ÖCOPA¾É¸õ·²¡Á²È²À­´Ö¼ÁÀ­ÇÙ±ê¤Î˶¸¡Îã¡×---COPA syndrome

Âç·î´²Ïº¤Û¤«¡ÊÉ;¾À»Îìɱ¡ ÉÂÍý¿ÇÃDzʡË

7.¡Ö¿ÇÃÇ¤ËÆñ½Â¤·¤¿Èé²¼¼ðáç¤Î°ìÎã¡×--malignant mixed tumor of the skin

ÀÐÀîÎå¤Û¤«¡ÊÉ;¾°å²ÊÂç³Ø¡¡ÉÂÍý¿ÇÃDzʡË

²ñ½ªÎ»¸å¡¡¡Ö¤Ò¤³¤Í¡×¤Ë¤ª¤¤¤ÆÇ¼Îòñ(¤Þ¤¿¡¢»²²Ã¤Ç¤­¤Ê¤«¤Ã¤¿.)

 

Âè264²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2017ǯ6·î24Æü(ÅÚ) ÀŲ¬»Ô, ÀŲ¬»ÔΩɱ¡À¾´Û11³¬²ñµÄ¼¼

1.¡ÖÂçÂÜÈé²¼¼ðáî¤Î£±Îã¡×-- hybrid schwannoma/ perineuroma

ÇϾ졡Áï¡¢¸åÆ£¿¿Æà¡ÊÃæÅì±óÁí¹ç°åÎÅ¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡË

2.¡ÖDM¡¡dermopathy ¤Î1Îã¡×

»°±º¹îÉÒ¡ÊÉ;¾°å²ÊÂç³Ø ·ò¹¯²Ê³Ø¡Ë

3.¡Ö¼£ÎŤ˶ìθ¤·¤¿¿Õ¼ðáî¤Î1Îã¡×-- maracoplakia

ÂçÄͽٲ𡢿¹ ¹°¼ù¡¢¾®ß·µý»Ë¡ÊÉ;¾°åÎÅ¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡË

4.¡Ö»ÒµÜÂÎÉô¤Î٨ʿ¾åÈé²½À¸¤òȼ¤¦ÎàÆâËìÁ£´â¤Î°ìÎã¡×

ĹÁÒÍ¥²Ö1)¡¢Ìܹõ»Ë¿¥2¡Ë¡Ê1¡ËÉ;¾°å²ÊÂç³ØÉí°É±¡ ÉÂÍý¿ÇÃDzʡ¢ ¡¡2¡ËƱ ºÆÀ¸´¶À÷ÉÂÍý³Ø¡Ë

5.¡ÖCD45/leukocyte common antigen(LCA)ÍÛÀ­ thymic poorly diff. squamous cell carcinoma ¤Î2¾ÉÎã-¼ðáçºÙ˦¤ÎͳÍè¤ò¹Í¤¨¤Æ¤ß¤Þ¤·¤¿¡×

벬½ñɧ¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡ ÉÂÍý¿ÇÃDzʡË

6.¡ÖIgG4´ØÏ¢¶»ÉôÂçÆ°Ì®±ê¤¬¹Í¤¨¤é¤ì¤¿¾å¹ÔµÝÉôÂçÆ°Ì®áî¤Î£±Îã¡×

¿¹ÌÚÍø¾¼¡ÊÀŲ¬»ÔΩÀجɱ¡ ÉÂÍý¿ÇÃDzʡË

7.¡Ö¾®Ç¾¼ðáç¤Î£±Îã¡×--Lhermitte-Duclos disease (Dysplastic cerebellar gangliocytoma)

ÅÚÅÄ¡¡¹§¡¢Â¿ÅÄË­Û¥¡ÊË­Àî»Ô̱ɱ¡ ÉÂÍý¿ÇÃDzʡË

¡ÚÏ¢Íí»ö¹à¡Û ¡¦¡Ö¾ëÆîÉÂÍý-SPS ¹çƱº©Ã̲ñ¡×¤Î¤ªÃΤ餻 ¡¦¡ÖÊ¿À®29ǯÅÙÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÀìÌçÉÂÍý°åÍÜÀ®¸¦½¤²ñ¡×¤Î¤ªÃΤ餻 ¡¦¤½¤Î¾

 

Âè263²óÀŲ¬¸©ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2017ǯ4·î15Æü(ÅÚ) 13:30-17:00 ÀŲ¬Ã˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¡Ö¤¢¤¶¤ì¤¢¡×4³¬ÆÃÊ̲ñµÄ¼¼

1. ¡Ö´Î¼ðáî¤ÎÀ¸¸¡¤Î°ìÎã¡×-- epithelioid hemangioendothelioma

À»Îì»°Êý¸¶É±¡¡¡ÉÂÍý¿ÇÃDzʡ¡È¬ÌÚ½ÕÆà¤Û¤«

2.¡¡¡Ö´Î¼ðáî¤Î°ìÎã¡×--epithelioid hemangioendothelioma

É;¾°å²ÊÂç³ØÉհɱ¡¡¡ÉÂÍý¿ÇÃDzʡ¡ÇϾìÁï¤Û¤«

3.¡¡¡ÖÇÙ¼ðáç¤Î°ì˶¸¡Îã¡×--pulmonary artery intimal sarcoma

É;¾°åÎÅ¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzʡ¡ÂçÄͽٲð¤Û¤«

4.¡¡¡Ö·«¤êÊÖ¤¹°ßÄÙá礬¸¶°ø¤È»×¤ï¤ì¤Æ¤¤¤¿°ßÍ©ÌçÉô¶¹ºõ¤Î°ìÎã¡×--adenocarcinoma arising in ectopic pancreas

¾ÆÄÅ»ÔΩɱ¡ÉÂÍý¿ÇÃDzʡ¡À¾ÅÄ¡¡½¨¤Û¤«

5.¡¡¡Ö¼ª²¼Á£¼ðáç¤Î°ìÎã¡×--intraductal carcinoma, low-grade (WHO2017)

É;¾°å²ÊÂç³ØÉհɱ¡¡¡ÉÂÍý¿ÇÃDzʡ¡ÇϾìÁï¤Û¤«

6.¡¡¡ÖÆÃ°Û¤ÊÁÈ¿¥Áü(Ç´±Õ»ºÀ¸Áü)¤òÄ褷¤¿¹Ã¾õÁ£´â¤Î°ìÎã¡×--papillary carcinoma, variant

ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡¡ÉÂÍý¿ÇÃDzʡ¡Á𿼡¡¸ø½¨

7.¡¡¡ÖÇÙ¼ðáç¤È¤·¤ÆÀÚ½ü¤µ¤ì¤¿Èó¼ðáçÀ­ÇÙÉÂÊÑ¡×--peribronchial metaplasia and extensive (alveolar) squamous metaplasia

ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡¡ÉÂÍý¿ÇÃDzʡ¡ÃæÅç¡¡¹§

8.¡¡¡ÖÀ¸¸¡¤Ç²½À¸´â¤¬µ¿¤ï¤ì¤¿ÆýÁ£¼ðáç¤Î°ìÎã¡×--DCIS and giant cell tumor(GCT)

ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¡ÎëÌÚĬ¿Í¤Û¤«

9. ¡Ö¶õIJ¼ðáç¤Î°ìÎã¡×-- gangliocytic paraganglioma of the jejunum

É;¾°å²ÊÂç³ØÉհɱ¡¡¡ÉÂÍý¿ÇÃDzʡ¡ÇϾìÁï¤Û¤«

10. ¡Ö¿Õ¼ðáç¤Î°ìÎã¡×--angiomyolipoma with predominantly smooth muscle differentiation and renal cell carcinoma

É;¾°å²ÊÂç³ØÉհɱ¡¡¡ÉÂÍý¿ÇÃDzʡ¡¸åÆ£¿¿Æà¤Û¤«

²ñ½ªÎ»¸åÀŲ¬»Ô¡Ö²Ø»Ò¤Î²Ö ̵°Ã¡×¤Ç¿·¿Í´¿·Þ²ñ.¡¡¿·¿ÍÉÂÍýÀì¹¶°å¡¡4¿Í

 

Âè262²óÀŲ¬¸©ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2017ǯ1·î28Æü(ÅÚ) 13:30-17:00 ÀŲ¬»ÔΩÀجɱ¡¡¡Åì´Û11³¬¡¡C²ñµÄ¼¼

1. ¡ÖÇÙ²á¸í¼ðÀ®Ê¬¤òȼ¤¤Â¿·ÁÆù¼ð¤ÎÁü¤ò¼¨¤·¤¿ÇÙ¼ðáç¤Î1²ò˶Îã¡×-- malignant mesenchymoma¤¬Ì¾¾Î¤È¤·¤ÆÅ¬ÀڤǤϡ£

À»Îì»°Êý¸¶É±¡¡¡ÉÂÍý¿ÇÃDzʡ¡È¬ÌÚ½ÕÆà¤Û¤«

2.¡¡¡Ö°ßSMTÍͼðáç¤Î°ì˶¸¡Îã¡×--epithelioid hemangiosarcoma

É;¾À¾Éô°åÎÅ¥»¥ó¥¿¡¼¡¡ÉÂÍý¿ÇÃDzʡ¡ÂçÄͽٲð

3.¡¡¡Ö¶â¤Î»å¤¬ÇÙÆ°Ì®¤ËÌÂÆþ¤·¤¿°ìÎã¡×

ÀŲ¬»ÔΩÀجɱ¡¡¡ÉÂÍý¿ÇÃDzʡ¡¹¾²Ïͦ¼ù¤Û¤«

4. ¡Ö´Î³°ÃÀ´É¼ðáî¤Î2Îã¡×

É;¾°å²ÊÂç³ØÉհɱ¡¡¡ÉÂÍý¿ÇÃDzʡ¡ÇϾìÁï¤Û¤«

5.¡¡¡Ötubular adenoma of the breast¡×--pseudomembranous colitis

ÀŲ¬ÀÖ½½»úɱ¡¡¡³Þ¸¶ÀµÃˤۤ«

6.¡¡¡ÖIJ´É¥¹¥Ô¥í¥Ø¡¼¥¿¾É¤Î2¾ÉÎã¡×

À»ÎìÉ;¾É±¡ÉÂÍý¿ÇÃDzʡ¡Âç·î´²Ïº¤Û¤«

7.¡¡¡Öº®¹çɽ¸½·¿µÞÀ­Çò·ìÉÂ, MPAL with t(9;22)(q34;q11.2); BCR-ABL1¤Î°ìÎã¡×

ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¡Ã«²¬½ñɧ¤Û¤«

8.¡¡¡ÖºÇ¶á·Ð¸³¤·¤¿¶½Ì£¤¢¤ë3Îã¡×-- phosphaturic mesenchymal tumor(CD56,SSTR2¤¬ÍÛÀ­¤Ë¤Ê¤êFGF23ÌȱÖÀ÷¿§¤Ç³Î¿Ç), IgG4-rellated lymphadenopathy, Eccrine angiomatous hamartoma

É;¾°å²ÊÂç³ØÉí°É±¡ ÉÂÍý¿ÇÃDzʡ¡ÅÚÅŧ¤Û¤«

 

Âè261²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2016ǯ12·î3Æü(ÅÚ¡ËÀŲ¬»ÔΩÀجɱ¡¡Ê11³¬ C²ñµÄ¼¼¡Ë

1.¡ÖEpithelioid sarcoma ¤È¿ÇÃǤµ¤ì¤¿¾ÉÎã¤ÎÀ¸¸¡»þ¿ÇÃÇ¡×

À»Îì»°Êý¸¶É±¡ ÉÂÍý¿ÇÃDzʡ¡È¬ÌÚ½ÕÆà¡¢¹â¶¶ÀÄ»ÖϺ¡¢¾®Àî Çî

2.¡ÖÊø²õ¤·¤¿ÆýÁ£¼ðáç¤Î£±Îã¡×

É;¾°åÎÅ¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡ¡¡¡ÂçÄͽٲð

3.¡ÖËýÀ­ÌôºÞÀ­´Î±ê¤Î£±Îã¡×

ÀŲ¬¸©Î©Áí¹çɱ¡ ÉÂÍý¿ÇÃDzʡ¡¡¡Â¼¾¾¡¡ºÌ

4.¡ÖǾ¼ðáç¤Î£±Îã¡¡£²ºÐ£¸¥õ·î ÃË»ù¡×

ÀŲ¬¸©Î©¤³¤É¤âɱ¡ ÉÂÍý²Ê¡¡ÉÍùõ¡¡Ë­

5.¡ÖBronchioloalveolar tumor with two cell growth pattern, hyperplasia or neoplasia¡×

ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡ¡ÃæÅç¡¡¹§

6.¡Ö°ßÇ´Ëì²¼¼ðáç¤Î£±Îã¡×

À»ÎìÉ;¾É±¡ ÉÂÍý¿ÇÃDzʡ¡¿·°æµÁʸ¡¢Âç·î´²Ïº¡¢¾®ÎÓ¡¡´²

7.¡Ö¹Ã¾õÁ£¼ðáç¡¡91ºÐ ½÷À­¡×

É;¾°å²ÊÂç³ØºÆÀ¸¡¦´¶À÷ÉÂÍý³Ø¹ÖºÂ¡¡¾®¿ù°Ë»°É×

8.¡ÖÉÔÌÀÇ®¡¢Ê¢¹Ð¥ê¥ó¥ÑÀá¼ðÂç¡¢Æù²ê¼ðÍÍÉÂÊѤ¬¤ß¤é¤ì¤¿ MCTD ¾ÉÎã¡×

É;¾°å²ÊÂç³Ø´ðÁôǸî·ò¹¯²Ê³Ø¡¡»°±º¹îÉÒ

9.¡ÖEwing-like sarcoma ¤Î£²Îã¡×

É;¾°å²ÊÂç³ØÉí°É±¡ ÉÂÍý¿ÇÃDzʡ¡Ê¡ÅèËãͳ

SPS ½ªÎ»¸å¤Ë¡Ö¤È¤ß°æ¡×¤Ç˺ǯ²ñ³«ºÅ¡£

 

Âè260²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

Âè260²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ï SPS-¾ëÆîÉÂÍý¹çƱº©Ã̲ñ¤Ç¤¹

2016ǯ10·î23Æü¡ÊÆü¡Ë¡¡ÅìµþÅÔ¹¾Åì¶èË­½§5-1-38 ¾¼ÏÂÂç³Ø¹¾ÅìË­½§É±¡£¹³¬¹ÖƲ

 

Âè259²óÀŲ¬¸©ÉÂÍý°å²ñ(SPS)

2016ǯ9·î3Æü(ÅÚ) 13:30-17:00 ÀŲ¬¸©Áí¹ç¼Ò²ñÊ¡»ã²ñ´Û¥·¥º¥¦¥§¥ë103²ñµÄ¼¼

1. ¡Öµ¤´É»Ù¼ðáç¤Î°ìÎã¡×-- gangliocytic paraganglioma

À»Îì»°Êý¸¶É±¡¡¡ÉÂÍý¿ÇÃDzʡ¡È¬ÌÚ½ÕÆà¤Û¤«

2.¡¡¡Ö´ÕÊ̤˶ìθ¤·¤¿ÆðÉô¼ðáç¤Î°ìÎã¡×--epithelioid sarcoma

É;¾°å²ÊÂç³ØÉí°É±¡¡¡ÉÂÍý¿ÇÃDzʡ¡ÀÐÀîÎå, Ê¡ÅèËãͳ

3.¡¡¡Ö·ì±ÕÁý¿£¼À´µ¤¬µ¿¤ï¤ì¤¿ÂçIJ±ê¤Î°ì˶¸¡Îã¡×--pseudomembranous colitis

ÀŲ¬ÀÖ½½»úɱ¡¡¡³Þ¸¶ÀµÃˤۤ«

4.¡¡¡Ö´ñ°Û¤Ê°ßÉÂÊѤΰìÎã¡×--Massive gastric polyposis with SMAD4 mutation

É;¾°å²ÊÂç³Ø¼ðáçÉÂÍý³Ø¹ÖºÂ¡¡¿ú¼½Õɧ¤Û¤«

5.¡¡¡Ö»ÒµÜÆâËì¾É¤òȼ¤¦Äã°Û·¿ÅÙÃî¿âÇ´±ÕÀ­¼ðáç¤Î°ìÎã¡×

ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¡ÎëÌÚĬ¿Í¤Û¤«

6.¡¡¡Ö¾åÍÕÍ¥°Ì·¿ÇÙÀþ°Ý¾É¤Î2¾ÉÎã¡×--ÆÃȯÀ­¾åÍÕÍ¥°Ì·¿ÇÙÀþ°Ý¾É(ÌÖëÉÂ)

À»ÎìÉ;¾É±¡ÉÂÍý¿ÇÃDzʡ¡¿·°æµÁʸ¤Û¤«

7.¡¡¡Ö¾®Ä²¼ðáç¤Î°ìÎã (³Êó: No253SPS)¡×--Luteinized adult granurosa cell tumor --> steroid cell tumor, NOS

É;¾°å²ÊÂç³ØÉí°É±¡ ÉÂÍý¿ÇÃDzʡ¡ÇϾìÁï¤Û¤«

¾ëÆîÉÂÍý-SPS ¹çƱº©Ã̲ñ: 10·î23Æü(Æü) 11-15»þ¡¡¾¼ÏÂÂç³Ø¹¾ÅìË­½§É±¡9³¬¹ÖƲ (À¤ÏÿÍ:¶åÅç̦¼ùÀèÀ¸)

 

Âè258²óÀŲ¬¸©ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2016ǯ6·î25Æü(ÅÚ)13¡§30¡Ý17¡§00 ÀŲ¬»ÔΩɱ¡Åì´Û 11³¬C²ñµÄ¼¼

1. ¡ÖÀèÅ·À­Â¿È¯½½Æó»ØÄ²Êĺ¿¾É¤Î1Îã¡×

À»ÎìÉ;¾É±¡ÉÂÍý¿ÇÃDzʡ¡Âç·î´²Ïº, ¿·°æµÁʸ

2. ¡ÖǾ¼ðáç¤Î1Îã(5ºÐÃË»ù)¡×-- undifferentiated sarcoma

ÀŲ¬¸©Î©¤³¤É¤âɱ¡¡¡ÉÂÍý²Ê¡¡ÉͺêË­, ´äÊ¥±Ñ¿Í

3. ¡Ö2ºÐ»ù¤ÎÂçÂÜÉô¤ËȯÀ¸¤·¤¿Èé²¼¼ðáî¤Î1Îã¡×--lipofibromatosis

É;¾°åÎÅ¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzʡ¡ÂçÄͽٲð, ¿¹¹°¼ù, ¾®ß·µý»Ë

4. ¡Ö¿ÕⳤËȯÀ¸¤·¤¿å°ÌÓÁ£¼ð¤Î1Îã¡×-- villous adenoma of the pelvis

ÈØÅÄ»ÔΩÁí¹çɱ¡¡¡ÎëÌÚĬ¿Í, ÂçÀ¾°ìÊ¿, 벬½ñɧ

5. ¡Öº¸¿´¼ªáî(68ºÐ½÷À­)¡×

ÀŲ¬¸©Î©Áí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¡Â¼¾¾ºÌ

6. ¡ÖÂñÕÁ£Ç¹Ë¦À­¼ðáî¤Î1Îã¡×-- low-grade variant of the salivary duct carcinoma

É;¾°å²ÊÂç³Ø°å³ØÉô ºÆÀ¸¡¦´¶À÷ÉÂÍý³Ø¹ÖºÂ¡¡Ìܹõ»Ë¿¥

7. ¡Ö¤¢¤ó¥Ñ¥óÍͤβèÁü·ÁÂÖ, Æù´ã·ÁÂÖ¤ò¼¨¤·¤¿ÆýÁ£¼ðáî(60ºÐ½÷À­)¡×-- invasive ductal carcinoma with large central acellular zone

¾ÆÄÅ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¡µ×Îϸ¢

²ñ½ªÎ»¸å¡¡¡Ö¤Ò¤³¤Í¡×¤Ë¤ÆÇ¼Îòñ³«ºÅ

 

Âè257²óÀŲ¬¸©ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2016ǯ4·î23Æü(ÅÚ)13¡§30¡Ý17¡§00 ÀŲ¬¸©Ã˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢¡¡Â¿ÌÜŪ¼Â½¬¼¼¡ÊÃϲ¼£±³¬)

1.¡ÖÃÀǹ¸¶È¯¤Î neuroendocrine carcinoma with adenocarcinoma component ¤Î°ìÎã¡×

ÂçÀ¾°ìÊ¿1,2¡¤ÎëÌÚĬ¿Í1¡¤¿ú¼½Õɧ£²¡¤Ã«²¬½ñɧ1¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzÊ1¡¤É;¾°å²ÊÂç³Ø¼ðáçÉÂÍý³Ø¹ÖºÂ£²¡Ë

2.¡ÖÈéÉæ¼ðáç¤Î1Îã¡×--Dermatofibrosarcoma protuberans with low-grade fibrosarcomatous component

ȬÌÚ½ÕÆà¡¢¹â¶¶ÀÄ»ÖϺ¡¢¾®Àî Çî¡ÊÀ»Îì»°Êý¸¶É±¡ÉÂÍý¿ÇÃDzʡË

3.¡Öµ¤¶»¤ò·«¤êÊÖ¤·¤ª¤³¤·¤¿Á°³ÛÉô·ì´ÉÆù¼ð¤Î£±Îã¡×--angiosarcoma of the skin metastasized to lung

¿¹ÌÚÍø¾¼¡¢¹¾²Ïͦ¼ù¡ÊÀŲ¬»ÔΩÀجɱ¡ÉÂÍý¿ÇÃDzʡË

4.¡ÖÀèÅ·À­¹â¥¤¥ó¥¹¥ê¥ó·ì¾É¡Ê£¶¥õ·î½÷»ù¡Ë¡×--Nesidioblastosis, focal form, adenomatous hyperplasia, pancreas

ÉÍùõ Ë­¡ÊÀŲ¬¸©Î©¤³¤É¤âɱ¡ÉÂÍý²Ê¡Ë

5.¡ÖĹ´üÆ©ÀÏ´µ¼Ô¤ËȯÀ¸¤·¤¿²óIJÀü¹¦¤Î£±Îã¡×--¥Ý¥ê¥¹¥Á¥ì¥ó¥¹¥ë¥Õ¥©¥ó»ÀCaÄÀÃå¤Ë¤è¤ë²óIJÀü¹¦

Âç·î´²Ïº¡¤¿·°æµÁʸ¡ÊÀ»ÎìÉ;¾É±¡ÉÂÍý¿ÇÃDzʡˡ¡

6.¡ÖÂñÕÁ£Æ³´É´â¤Ë¤ª¤±¤ë¥¢¥ó¥É¥í¥²¥ó¼õÍÆÂΤÎʬ»ÒÉÂÍý³ØÅª¸¡Æ¤¡×

ºù°æ¹ÀÊ¿£±¡Ë¡¢³Þ¸¶ÀµÃË£²¡Ë¡¢ÅÄÂåϹ°£²¡Ë¡¢Ïº´Ìî¹À°ìϺ£³¡Ë¡¢°ðÅÄ·ò°ì£±¡Ë¡ÊÆ£ÅÄÊÝ·ò±ÒÀ¸°å³ØÉôÉÂÍý²Ê­¶£±¡Ë¡¢ÀŲ¬ÀÖ½½»úɱ¡ÉÂÍý¿ÇÃDzÊÉô£²¡Ë¡¢ÀŲ¬ÀÖ½½»úɱ¡¼ªÉ¡°ö¹¢²Ê£³¡Ë¡Ë

7.¡ÖÃÀǹ±ê¤Î¼ê½Ñ¤Ç¸«¤Ä¤«¤Ã¤¿¥Ý¥ê¡¼¥×ÍÍÉÂÊѤÎ1Îã¡×--carcinosarcoma (¤µ¤é¤Ë¸¡Æ¤¤¬É¬ÍסË

ÂçÄͽٲ𡢿¹ ¹°¼ù¡¢¾®ß·µý»Ë¡ÊÉ;¾°åÎÅ¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzʡË

 

Âè256²óÀŲ¬¸©ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2016ǯ2·î13Æü(ÅÚ) ÀŲ¬»ÔÀŲ¬»ÔΩÀجɱ¡ À¾´Û12F¹ÖƲ

1.¡ÖDeep benign fibrous histiocytoma¤È¿ÇÃǤµ¤ì¤¿2Îã¡×

(1) cutaneous solitary fibrous tumor ¤È(2) nodular fasciitis
ÇϾì Áï¡¡É;¾°å²ÊÂç³Ø°å³ØÉôÉí°É±¡, ÉÂÍý¿ÇÃDzÊ

2. ¡ÖÌçÌ®°µÐ¶¿Ê¾É¤Î1Îã¡×- idiopathic portal hypertention (IPH) [Banti¾É¸õ·²]

Ìܹõ»Ë¿¥¤Û¤« É;¾°å²ÊÂç³ØºÆÀ¸¡¦´¶À÷ÉÂÍý³Ø¹ÖºÂ

3.¡ÖÃî¿â¼ðáî¡×10ºÐÂå½÷»ù - adenocarcinoma in villous adenoma

ÉͺêË­¡¡ÀŲ¬¸©Î©¤³¤É¤âɱ¡ÉÂÍý²Ê

4.¡Ö¸å½Ä³Ö¤Î¼ðáçÍÍÉÂÊѤȤ·¤ÆÅ¦½Ð¤µ¤ì¤¿¿ñ³°Â¤·ìÁã¤Î1Îã¡×

ÎëÌÚĬ¿Í¤Û¤«¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzÊ

5.¡Ö¾Ë»Ò²½º÷¾õ¼ðáç¤ÈÆýƬ´â¤ò¹çÊ»¤·¤¿¹Ã¾õÁ£¼ðáç¤Ë¤ª¤±¤ëÉÂÍýÁÈ¿¥³Ø¤ª¤è¤ÓºÙ˦³ØÅª¸¡Æ¤¡×

¹Ã¾õÁ£¾Ë»Ò²½º÷¾õ¼ðáç ÆýƬ´â
²¬ÉôËã»Ò¤Û¤«¡¡Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³ØÉ±¡ÉÂÍý¿ÇÃDzÊ, ÀŲ¬ÀÖ½½»úɱ¡ÉÂÍý¿ÇÃDzÊÉô

6.¡ÖÀ¸¸¡¤Çfibromatosis-like metaplastic carcinoma¤òµ¿¤Ã¤¿1Îã, ¤½¤Î¸å¡×Æý˼

ÅÚÅÄ ¹§¡¡É;¾°å²ÊÂç³ØÉí°É±¡ ÉÂÍý¿ÇÃDzÊ

7. ´Î¼ðáç¤È¿ȯÇÙ·ì´ÉÉÂÊѤòǧ¤á¤¿1Îã, ¤½¤Î¸å

ÃæÅç ¹§ ÀŲ¬¸©Î©¤¬¤ó¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzÊ

 

Âè255²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

1.¡Ö»ÒµÜ¸¶È¯¤Î°­À­¥ê¥ó¥Ñ¼ð¤È¿ÇÃǤµ¤ì¤¿Ë¶¸¡Îã¡×

ÂçÄͽٲð¡ÊÉ;¾°åÎÅ¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzʡË

2.¡ÖÀ®¿ÍTºÙ˦Çò·ìɤΰì˶¸¡Îã¡Ê79ºÐ¡¦ÃËÀ­¡Ë¡×

ȬÌÚ½ÕÆà¡¢¹â¶¶À¶»ÖϺ¡¢¾®Àî Çî¡ÊÀ»Îì»°Êý¸¶É±¡ÉÂÍý¿ÇÃDzʡË

3.¡Ö±¦¸åƬÍÕ¤ÎǾ¼ðáç¾ÉÎã¡Ê13ºÐ¡¦½÷»Ò¡Ë¡×

ÉÍùõ Ë­¡ÊÀŲ¬¸©Î©¤³¤É¤âɱ¡ÉÂÍý²Ê¡Ë¡¡

4.¡Öº¸¼ª²¼Á£¼ðáç¤Î°ìÎã¡×

Á𿼸ø½¨¡ÊÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzʡË

5.¡Ö´Î¼ðáç¤È¿ȯÇÙ·ì´ÉÉÂÊѤòǧ¤á¤¿£±¾É¡×

ÃæÅç¡¡¹§¡ÊÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzʡË

6.¡Ö¿Õ angiomyolipoma with epithelial cysts ¤Î£±¾ÉÎã¡×

Âç·î´²Ïº¡ÊÀ»ÎìÉ;¾É±¡ÉÂÍý¿ÇÃDzʡË

7.¡Öç¯æù¤ËȯÀ¸¤·¤¿ÌÀºÙ˦·¿Ç¢Ï©¾åÈé´â¤Î1Îã¡×

ÎëÌÚĬ¿Í1¡¤ÂçÀ¾°ìÊ¿1¡¤ÀÄÌڹ⹭2¡¤¿ú¼½Õɧ3¡¤Ã«²¬½ñɧ1¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzÊ1¡¤ÈØÅÄ»ÔΩÁí¹çɱ¡ÈçÇ¢´ï²Ê2¡¤É;¾°å²ÊÂç³Ø¼ðáçÉÂÍý³Ø3¡Ë

8.¡ÖÌó£³Ç¯´Ö Parkinson disease ¤Î¿ÇÃÇ´ð½à¤Ë½¾¤¤²ÃÎÅÃæ¡¢¸íÓëÀ­ÇÙ±ê¤Ç»àË´¡¢Ë¶¸¡¤Ë¤ÆÂçǾÈé¼Á´ðÄì³ËÊÑÀ­¾É¡Êcorticobasal degeneration; CBD)¤È¿ÇÃǤµ¤ì¤¿£±¾ÉÎã¡×

³Þ¸¶ÀµÃË£±¡¢È¬ÌÚ¿®¹¯£²¡¢¹âÈø¾»¼ù£³¡¢ÅÄÂåϹ°£±¡¢²¬ÉôËã»Ò£´¡ÊÀŲ¬ÀÖ½½»úɱ¡ÉÂÍý¿ÇÃDzÊÉô£±¡¢Æ±¿À·ÐÆâ²Ê£²¡¢ºë¶Ì°å²ÊÂç³Ø¿À·ÐÆâ²Ê£³¡¢Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³Ø°å³ØÉôÉÂÍý¿ÇÃDzʣ´¡Ë

Âè254²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

Âè254²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ï¾ëÆî-ÀŲ¬ÉÂÍý¹çƱ¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ç¤¹¡£

 

Âè253²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2015ǯ8·î30Æü(ÅÚ) 13:30-17:00 ÀŲ¬»ÔΩÀجɱ¡À¾´Û12³¬¹ÖƲ

1. ¡Ö¾®Ä²¼ðáç¤Î°ìÎã¡×82ºÐ½÷À­¡¡¾®Ä² --- Late metastasis of ovarian luteinized adult granulosa cell tumor

ÇϾìÁï¡¡É;¾°åÂçÉí°É±¡ÉÂÍý¿ÇÃDzÊ

2. ¡Ö¿ÇÃÇ¤ËÆñ½Â¤·¤¿º¸ÆýÁ£¼ðáç¤Î°ìÎã¡×56ºÐ½÷À­¡¡Æý˼¡¡--- fibromatosis-like metaplastic carcinoma, suspicious of

ÅÚÅŧ¡¡É;¾°åÂçÉí°É±¡ÉÂÍý¿ÇÃDzÊ

3. ¡Ö±¦²¼ÍÕ¤ÎÁÈ¿¥É¸Ëܾå¤Ë13¸Ä¤Î¼ðáçÉÂÊѤ¬Ç§¤á¤é¤ì¤¿ÇÙ¸¶È¯À­ÆýƬ¾õÁ£´â¤ÎÁÈ¿¥È¯À¸¤Ë¤Ä¤¤¤Æ¡×80ºÐÂåÃËÀ­~¡¡

³Þ¸¶ÀµÃË ²¬ÉôËã»Ò¡¡ÀŲ¬ÀÖ½½»úɱ¡ÉÂÍý²Ê¡¢Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³Ø°å³ØÉôÉÂÍý²Ê

4. ¡ÖÂçÆ°Ì®ÊÛ¤ÎÏ·²½¤Ë¤È¤â¤Ê¤¦ÊѲ½¤Ë¤Ä¤¤¤Æ¡×»°±º¹îÉÒ¡¡É;¾°åÂç´ðÁôǸî·ò¹¯²Ê³Ø

5. ¡Ö´¶À÷À­¿´ÆâËì±ê¤Î°ì¾ÉÎã¡×---mesothelial/monocystic incidental cardiac excrescences(MICE)

ȬÌÚ½ÕÆà¡¡À»Îì»°Êý¸¶É±¡ÉÂÍý¿ÇÃDzÊ

6. ¡ÖMarphan¤Î¿´·ì´ÉÉÂÊÑ¡×---Marphan syndrome

»°±º¹îÉÒ¡¡É;¾°åÂç´ðÁôǸî·ò¹¯²Ê³Ø

²ñ½ªÎ»¸å¡¡¡Ö¤Ò¤³¤Í¡×¤Ë¤ÆÇ¼Îòñ³«ºÅ

 

Âè252²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2015ǯ5·î30Æü(ÅÚ) 13:30-17:00 ÀŲ¬»ÔÃ˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢B4 ¿ÌÜŪ¼¼

1. ¡Ö20ǯ¤«¤±¤ÆÁýÂ礷¤¿ÇÙ¼ðáç¤Î°ìÎã¡×--- malignant solitary fibrou tumor arising in the lung

ȬÌÚ½ÕÆà¤Û¤«¡¡À»Îì»°Êý¸¶É±¡ÉÂÍý¿ÇÃDzÊ

2. ¡Ö¼«Á³Âà½Ì¤òÍ褿¤·¤¿ÇÙ´â¤Î2¾ÉÎã¡×

Âç·î´²Ïº¤Û¤«¡¡À»ÎìÉ;¾É±¡ÉÂÍý¿ÇÃDzÊ

3.¡¡¡ÖMacroglobulinemia3¾ÉÎã¤ÎMYD88 L265P mutation¤Ë¤è¤ëÊä½õ¿ÇÃÇ¡×

ÂçÀ¾°ìÊ¿¤Û¤«¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzÊ

4.¡¡¡ÖAML¤Ë¤ÆÆþ±¡¸å myeloid sarcoma (leukemia cutis)¤È¿ÇÃǤµ¤ì¹ü¿ñ°Ü¿¢¸åÁ´¿È½ô¡´ï¤ËµÞÀ­GVHD¤òȯ¾É¤·¤¿1Îã¡×

²¬ÉôËã»Ò¤Û¤«¡¡Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³Ø°å³ØÉôÉÂÍý¿ÇÃDzʡ¢ÀŲ¬ÀÖ½½»úɱ¡ÉÂÍý¿ÇÃÇÉô

5.¡¡¡Öº¸ÀºÁã¼ðáç--12ºÐÃË»ù¡×--- mixed germinal cell tumor

ÉͺêË­¡¡ÀŲ¬¸©Î©¤³¤É¤âɱ¡ÉÂÍý²Ê

6.¡¡¡ÖÍñÁãÌÀºÙ˦¼ðáç¤Î°ìÎã¡×

ÂçÄͽٲð¤Û¤«¡¡É;¾°åÎÅ¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzʡ¡

7.¡¡¡Ö·ÛÉô¼ðáî¤Î°ìÎã¡×---plexiform schwannoma

Á𿼸ø½¨¡¡ÀŲ¬¸©Î©¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzÊ

8.¡¡¡ÖEvans¾É¸õ·²¤¬µ¿¤ï¤ì¤¿¹âÅÙÉÏ·ì¤Î°ìÎã¡×33ºÐÃËÀ­

Áð´Öͳµª»Ò¤Û¤«¡¡É;¾°å²ÊÂç³ØÉհɱ¡ÉÂÍý¿ÇÃDzÊ, ÀŲ¬ºÑÀ¸²ñÁí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¡

 

Âè251²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2015ǯ3·î21Æü(ÅÚ) 13:30-17:00 ÀŲ¬»ÔÃ˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢B4 ¿ÌÜŪ¼¼

1. ÂÛ»ù´ü¤Ëȯ¸«¤µ¤ì¤¿Éû¿Õ¼ðáç¤Î°ìÎã¡¡28dayÃË»ù ȬÌÚ½ÕÆà, Ê¡ÅèËãͳ, ÇϾìÁï, ÉͺêË­ ¸©Î©¤³¤É¤âɱ¡) neuroblastoma

2. Çò·ìɤ˹çÊ»¤·¤¿¿¿¶Ý´¶À÷¾É¡¡10ºÐ½÷»ù ÉͺêË­(ÀŲ¬¸©Î©¤³¤É¤âɱ¡) B lymphoblastic lymphoma and systemic mucormycosis

3. ±¦ÍñÁã¤ËÀ¸¤¸¤¿endometrioid adenocarcinoma with mucinous change¤Î°ìÎã 47ºÐ½÷À­¡¡ÂçÀ¾°ìÊ¿, ÎëÌÚĬ¿Í, ¿óâú´»Ò, ¿ú¼½Õɧ, 벬½ñɧ(ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzÊ, ƱÎ×¾²¸¡ºº²Ê, É;¾°åÂç¼ðáçÉÂÍý³Ø)

4. ǢƻÌÀºÙ˦Á£´â¤Î1Îã 40ºÐÂå½÷À­ Âç·î´²Ïº(À»ÎìÉ;¾É±¡) clear cell adenocarcinoma arising in urethral diverticum

5. Ìô¿¾¤¬µ¿¤ï¤ì¤¿1Îã- áÎáý¾É, 75ºÐÃËÀ­¡¡ÇϾìÁï¡ÊÉ;¾°åÂçɱ¡ÉÂÍýÉô) SCABIES¡¡ÈéÉæáÎáý¾É

6. Á´¿ÈÀ­¥ê¥ó¥ÑÀá¼ðÂç¡¡50ºÐÂåÃËÀ­¡¡ÎëÌÚÀ¿, ¼¼ÇîÇ·, ¿·°æ°ì¼é¡ÊÀŲ¬¸©Î©Áí¹çɱ¡) diffuse large B-cell lymphoma followed by classical Hodgkin lymphoma

7. °ß°­À­¥ê¥ó¥Ñ¼ð¤¬µ¿¤ï¤ì¤¿1Îã 67ºÐ½÷À­ ÅÏîµÎï»Ò¡ÊÀŲ¬¸©Î©¤¬¤ó¥»¥ó¥¿¡¼¡Ëlymphomatoid gastropathy

 

Âè250²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2015ǯ1·î24Æü(ÅÚ)¡¡13:30-17:00 ÀŲ¬»ÔΩÀجɱ¡¡¦À¾´Û12³¬¹ÖƲ

1. Ê¢¹ÐÆâ¼ðáî¤Î1Î㡡ȬÌÚ½ÕÆà, Á°Â¿¾¾´î(É;¾°å²ÊÂç³ØÉí°É±¡, Ë­¶¶»Ô̱ɱ¡) Castleman disease + follicular dendritic cell tumor

2. ¿À·ÐÈéÉæ¹õ¿§¾É 10ºÐ½÷À­ ÉͺêË­ (ÀŲ¬¸©Î©¤³¤É¤âɱ¡) neuroctaneous melanosis + meningeal melanocytosis/ melanomatosis

3. Á´¿È¥ê¥ó¥ÑÀáž°Ü, Ǿž°Ü¤ò¤­¤¿¤·¤¿¸¶È¯ÉÔÌÀ´â¤Î1Îã¡¡ÂçÀ¾°ìÊ¿¤Û¤«(ÈØÅÄ»ÔΩÁí¹çɱ¡, É;¾°åÂç¼ðáçÉÂÍý³Ø¹ÖºÂ) high-grade adenocarcinoma, mixed type of the lt. fallopian tube

4. ÈéÉæ¤Î¿ȯ¥Þ¥Ã¥·¥å¥ë¡¼¥à·¿¼ðáî¤Î1Îã¡¡¼¼ÇîÇ·¤Û¤«(ÀŲ¬¸©Î©Áí¹çɱ¡, É;¾°å²ÊÂçºÆÀ¸¡¦´¶À÷ÉÂÍý³Ø¹ÖºÂ)

5. ¤Þ¤ì¤ÊÁÈ¿¥Áü¤òÄ褷¤¿°ß´â¤ÈÁá´üÂçIJ´â¤È¤Î½ÅÊ£´âÎã ³Þ¸¶ÀµÃˤۤ«(ÀŲ¬ÀÖ½½»úɱ¡, Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³ØÉÂÍý¿ÇÃDzÊ) stomach; tubular adenocarcinoma with sarcomatous differentiation. rectum/sigmoid colon; tubular adenoacrinoma, moderately diff.

6. ¤Þ¤ì¤ÊÁÈ¿¥·Á¤ò¼¨¤·¤¿Æý´â¤Î1Îã¡¡ÀаæÏ¯»Ò¤Û¤«(ÀŲ¬¸©Î©¤¬¤ó¥»¥ó¥¿¡¼) lipid-rich carcinoma with micropapillary pattern

7. ÇÙ¥¢¥ß¥í¥¤¥ÉÍÍ·ëÀá¤Î1Îã¡¡¹¾²Ïͦ¼ù¤Û¤«(ÀŲ¬»ÔΩÀجɱ¡) pulmonary hyalinizing granuloma; right chain deposition

8. ·ÛÉô¥ê¥ó¥ÑÀá¼ðáç¤Î1Îã¡¡ÂçÄͽٲð¤Û¤«(É;¾°å²ÊÂç³ØÉí°É±¡, Ë­¶¶»Ô̱ɱ¡) interdigitating dendritic cell sarcoma

¾ÉÎ㸡Ƥ²ñ½ªÎ»¸å¡¡¡Ö¤Ò¤³¤Í¡×¤Çº©¿Æ²ñ

 

Âè249²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

Âè249²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ï¾ëÆî-ÀŲ¬ÉÂÍý¹çƱ¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ç¤¹¡£

Âè248²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2014ǯ10·î18Æü(ÅÚ)¡¡ÀŲ¬»ÔÃ˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢B1¡¡Â¿ÌÜŪ¼¼

1. æú¹ü¼ðáç¤Î1Îã¡§81ºÐÃËÀ­¡¡Ê¡ÅçËãͳ, ÇϾìÁï¡¡É;¾°åÂçÉհɱ¡ myeloid sarcoma with megakaryocytic differentiation (megakaryocytic sarcoma)

2. ¥¿¥â¥­¥·¥Õ¥§¥óÎÅË¡Ãæ¤Î»ÒµÜÆâËì¥Ý¥ê¡¼¥×¾õÉÂÊѤÎ1Îã 20ºÐÂå½÷À­¡¡Ìܹõ»Ë¿¥, ÎëÌÚÀ¿¡¢¿·°æ°ì¼é, ¼¼ÇîÇ·¡¡É;¾°å²ÊÂç³Ø, ÀŲ¬¸©Î©Áí¹çɱ¡ Borderline mixed epithelial and mesenchymal tumor or low-grade adenosarcoma

3. EBV´ØÏ¢¥ê¥ó¥ÑÁý¿£¾É¤Î°ìÎã 81ºÐÃËÀ­¡¡¼¼ÇîÇ·¡¡ÀŲ¬¸©Î©Áí¹çɱ¡ age-related EBV associated LPD of the stomach

4. ÇÙ¤ÎNUT midline carcinoma¤Î°ìÎã¡¡36ºÐ½÷À­¡¡ÎëÌÚĬ¿Í, ÂçÀ¾°ìÊ¿, ¿ú¼½Õɧ, 벬½ñɧ¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃÇ¡¢É;¾°å²ÊÂç³Ø¼ðáçÉÂÍý³Ø¹ÖºÂ

5. ¹â·ì°µ¤òȼ¤Ã¤¿¿Õ¼ðáç¾ÉÎã 15ºÐ¡¡½÷À­¡¡ÉͺêË­¡¡ÀŲ¬¸©Î©¤³¤É¤âɱ¡ jaxtaglomerular cell tumor of the kidney (JGCT)

6. ÆýÁ£¼ðáç¤Î°ìÎã¡¡30ºÐÂå¸åȾ½÷À­¡¡Âç·î´²Ïº¡¡À»ÎìÉ;¾É±¡ periductal stromal sarcoma and invasive ductal carcinoma

7. ºÇ¶á·Ð¸³¤·¤¿ÇÙ¼ðáç¤Î°ìÎã 79ºÐ½÷À­¡¡ÃæÅç¹§¡¡ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ mucinous AIS-like bronchiolar cell hyperplasia [ (Lambertosis) Peribronchiolar metaplasia]

 

Âè247²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2014ǯ8·î31Æü¡¡ÀŲ¬»ÔΩÀجɱ¡¡¡À¾´Û12³¬¹ÖƲ

£±. ¼ª²ðÈéÉæ¼ðáç¡§12ºÐ½÷À­ ÇϾ졡Áï¡ÊÉ;¾°åÂç¡ËAtypical cellular blue nevus

£²¡¥Î×¾²Åª¤ËǾ°­À­¥ê¥ó¥Ñ¼ð¡¢Ç¾Ç¿áç¡¢¤Ê¤¤¤· CNS ¥ë¡¼¥×¥¹¤¬µ¿¤ï¤ì¡¢À¸¸¡¤Ç¹â°­À­ÅÙ¥°¥ê¥ª¡¼¥Þ¤È¿ÇÃǤ·¤¿£±Îã
Ê¡ÅèËãͳ¡ÊÉ;¾°åÂç¡ËProgressive multifocal leukoencephalopathy with atpical astrocytic proliferation

£³¡¥Ù¨Ê¿¾åÈé´â¤Ø¤Îʬ²½¤¬ÃøÌÀ¤Ê»ÒµÜÆâËìÁ£´â¤ÈÍñÁã¤Î»ÒµÜÎàÆâËìǹ¼ð¤òȼ¤¦Ù¨Ê¿¾åÈé´â¤Î£²Îã
¶Í»³Í¡ÏÂ¡ÊÆ£ÅÄÊÝ·ò±ÒÀ¸Âç)¡¢³Þ¸¶ÀµÃË¡¢ÅÄÂåϹ°¡ÊÀŲ¬ÀÖ½½»úɱ¡¡ËÉÂÍý¿ÇÃÇ: ɽÂê¤ËƱ¤¸

£´¡¥À¸¸å£·Æü(F)¡§ Èé²¼¡¢¹ü¤Î¿ȯÉÂÊÑ¡¢·ëIJÉÂÊÑ Éͺꡡ˭¡ÊÀŲ¬¸©Î©¤³¤É¤âɱ¡¡ËInfantile myofibromatosis, multicentric

£µ¡¥Ä²´É¶¹ºõ¤¬¸«¤é¤ì£Ó¾õ·ëIJ´â¤¬µ¿¤ï¤ì¤¿£±Îã¡×¿¹¡¡¹°¼ù¡ÊÉ;¾°åÎÅ¥»¥ó¥¿¡¼¡ËAtypical endosalpingosis with endometriosis of the sigmoid colon

£¶¡¥±¦ÂçÂÜÈéÉæ¼ðáç¡§29ºÐ½÷À­¡×ÇϾ졡Áï¡¢¸åÆ£¿¿Æà¡ÊÉ;¾°åÂç¡ËMyoepithelioma, suspicious of, of the skin

Ï¢Íí»ö¹à

  • 1.ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍýÀìÌç°åÍÜÀ®¸¦½¤²ñ¡¡£¹·î20Æü¡ÊÅÚ¡Ë¡ÊÀŲ¬¥°¥é¥¦¥ó¥É¥Û¥Æ¥ëÃæÅç²°¡Ë
  • 2.Âè248²óSPS¡¡10·î18Æü¡ÊÅÚ¡ËÀŲ¬¸©Ã˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢
  • 3.¾ëÆîÉÂÍý-SPS¹çƱ¥«¥ó¥Õ¥¡¡¡11·î15Æü¡ÊÅÚ¡ËÅìµþÅÔΩ·ò¹¯Ä¹¼÷°åÎÅ¥»¥ó¥¿¡¼
  • 4.¤½¤Î¾
 

Âè245²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2013ǯ8·î31Æü¡¡ÀŲ¬¾¦¹©²ñ¡¡¸á¸å1:30¡Á¡¡6Âê¤Î±éÂ꤬ȯɽ¤µ¤ì¤Þ¤·¤¿¡£

1. ÃøÌÀ¤Ê¹¥»Àµå¿»½á¤òȼ¤Ã¤¿Èé²¼¼ðáî¤Î2Îã
ÇϾì Áï, Ìܹõ »Ë¿¥ ¡ÊÉ;¾°åÂçÉհɱ¡, É;¾°åÂçºÆÀ¸¡¦´¶À÷ÉÂÍý¡Ë
1Îã¤Ïkimura disease. ¤â¤¦1Îã¤Ï´ÕÊÌ¿ÇÃǤÇangiolymphoid hyperplasia with eosinophilia (Ìܹõ)

2. p53°äÅÁ»Ò¤Îµ©¤ÊÊѰÛ, M133K¤òÍ­¤¹¤ëľIJ¿À·ÐÆâʬÈç´â¤Î1Îã
ÂçÀ¾°ìÊ¿¤Û¤« (ÈØÅÄ»ÔΩÁí¹çɱ¡ ÉÂÍý¿ÇÃDzÊ)

3¡¥¥µ¥ë¥³¥¤¥É¡¼¥·¥¹¤Ë¹çÊ»¤·¤¿PML¤Î°ìÎã
¹¾²Ïͦ¼ù¤Û¤« (ÀŲ¬»ÔΩÀجɱ¡ ÉÂÍý¿ÇÃDzÊ)

4¡¥ÍñÁã¼ðáç
À¶¿å¿Ê°ì¤Û¤«¡¡¡ÊÀ»ÎìÉ;¾É±¡¡¡ÉÂÍý¿ÇÃDzÊ)
common epithelial tumor¤Èyolk sac tumor¤Îʻ¸¾ÉÎã¡£ÁÈ¿¥È¯À¸¤¬ÌäÂê¤Ç, ¤µ¤é¤Ë50ºÐÂå¤È¤¤¤¦È¯¾ÉǯÎð¤Ï¤É¤¦¤«¡£

5. ç¯æù¼ðáç¤Î2Îã
ÇϾì Áï (É;¾°åÂçÉí°É±¡ÉÂÍýÉô)
1Îã¤Ïclear cell adenocarcinoma (vs. adenocarcinoma NOS) 70ºÐÂåÃËÀ­ ç¯æù
¤â¤¦1Îã¤Ï Non-invasive urothelial carcinoma, with feature of lymphoma-like/plasmacytoid variant 80ºÐÂåÃËÀ­ ç¯æùÊÉÆýƬ¾õÉÂÊÑ

6. ÈéÉæ¼ðáç¤Î2Îã
ÇϾì Áï (É;¾°åÂçÉí°É±¡ÉÂÍýÉô)
1Îã¤ÏAtypical fibroxanthoma (AFX), 80ºÐÂåÃËÀ­¡¡¼ªÁ°ÉôÈé²¼¼ðáî
1Îã¤Ï Langerhans cell histiocytosis, 20ºÐÂåÁ°È¾½÷À­¡¡³°±¢Éô¿ȯ¥Ý¥ê¡¼¥×

 

Âè244²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2013ǯ6·î20Æü¡¡ÃæÅì±ó°åÎÅ¥»¥ó¥¿¡¼ ¿·É±¡¤Î¹ÖƲ¤Ç¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤¬¹Ô¤ï¤ì¤Þ¤·¤¿¡£

1. ÀÚ½ü¤ÈºÆÈ¯¤ò·«¤êÊÖ¤·¤¿±¦²¼´ãâÛÈé²¼¼ðáî¤Î1Îã
ÄÅµ×°æ ¹¨·Ã¡¡É;¾°å²ÊÂç³ØÉí°É±¡ÉÂÍý¿ÇÃÇ²Ê Desmoplastic melanoma. 70ºÐÂå½÷À­¡¡±¦²¼´ãâÛÈé²¼·ëÀá

2. º¸¸åðôÉôÈé²¼¼ðáî ÇϾì Áï É;¾°å²ÊÂç³ØÉí°É±¡ÉÂÍý¿ÇÃÇ²Ê Desmoplastic melanoma. 79ºÐ½÷À­¡¡S-100 positive spindle cells. DM or MPNST? ´ÕÊ̺¤Æñ¡£

3. ¼ê¤Ä¤Ê¤®´â »°±º ¹îÉÒ É;¾°å²ÊÂç³Ø´Ç¸î³ØÉô gastric cancer of "hand-shaking" type 50ºÐÂåÃËÀ­¡¡°ß

4¡¥Behcet disease ¤ÎIJ´ÉÉÂÊÑ
»°±º ¹îÉÒ É;¾°å²ÊÂç³Ø´Ç¸î³ØÉô
ÌÕIJ·ÜÍñÂç¼ðáî

5. myogenin ÍÛÀ­¤ò¼¨¤·¤¿Á°½Ä³ÖȯÀ¸large cell neuroendocrine carcinoma(LCNEC)¤Î°ìÎã
ÂçÀ¾ °ìÊ¿¤Û¤«¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡ ÉÂÍý¿ÇÃDzÊ

6¡¥Æ¬³¸Äì¼ðáç¤Î°ìÎã
¸åÆ£ ¿¿Æà¤Û¤«¡¡ÀŲ¬¸©Î©Áí¹çɱ¡ÉÂÍý¿ÇÃDzÊ
Epithelial-myoepithelial carcinoma 80ºÐÂåÃËÀ­

7¡¥º¸¿Õ¼ðáç¤Î°ìÎã À¶¿å¿Ê°ì¤Û¤«¡¡À»ÎìÉ;¾É±¡ÉÂÍý 60ºÐÂåÃËÀ­´µ¼Ô¤µ¤ó¡£ ÆýƬ¾õ¿ÕºÙ˦´â PRCC(solid variant, low-grade spindle cell foci) or Ç´±Õ´É¾õË¿îºÙ˦´â MTSCC (mucin-poor variant)

Âè243²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2013ǯ4·î20Æü¸á¸å1:30¡Á¡¡¡÷ÀŲ¬¸©Ã˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢4³¬²ñµÄ¼¼¡¡5Âê¤Î±éÂ꤬ȯɽ¤µ¤ì¤Þ¤·¤¿¡£

£±¡¥¡ÖOsler-Weber-RenduɤËÀ¸¤¸¤¿Â¿È¯À­´Î·ëÀáÀ­ÉÂÊÑ¡×: 1. focal nodular hyperplasia-like nodule 2. telangiectasis(Osler-Weber-Rendu disease)
¿·°æµÁʸ¡¢¹¾²Ïͦ¼ù¡¢Âç·î´²Ïº¡¢À¶¿å¿Ê°ì¡ÊÀ»ÎìÉ;¾É±¡¡Ë

£²¡¥Á𿼠¸ø½¨¡ÊÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡Ë ¡¡¡ÖÊ£»¨¤ÊÁÈ¿¥Áü¤òÄ褷¤¿°ß´â¤Î£±Îã¡×

£³¡¥¡Öº¸´éÌÌËËÉôÍ­·ÔÀ­¼ðáç¤Î£±Îã¡×¡§compatible with so called (cutaneous) mixed tumor
³Þ¸¶ÀµÃË¡¦ÅÄÂåϹ°¡ÊÀŲ¬ÀÖ½½»úɱ¡¡Ë¡¦¶Í»³Í¡ÏÂ¡ÊÆ£ÅÄÊÝ·ò±ÒÀ¸Âç³Ø¡Ë ¡¡¡¡ £´¡¥¡ÖÉ¡ÈéÉæ¼ðáî¤Î1Îã¡×¡§pseudolymphomatous folliculitis
ÇϾ졡Áï (É;¾°å²ÊÂç³ØÉհɱ¡ÉÂÍý¿ÇÃDzÊ)

£µ¡¥¡ÖÂçIJ¿ȯ¥Ý¥ê¡¼¥×¤Î1Îã¡×: Mantle cell lymphoma manifesting as multiple lymphomatous polyposis
ÇϾ졡Áï (É;¾°å²ÊÂç³ØÉհɱ¡ÉÂÍý¿ÇÃDzÊ)

SPS¤Î¤¢¤È¡¢16»þ¤«¤éÀŲ¬±ØÆî¤Î¡Ö¥Û¥Æ¥ë¥»¥ó¥Á¥å¥ê¡¼ÀŲ¬¡×¤Ç¡Ö°äÅÁ»Ò¸¡ºº¤Î¥»¥ß¥Ê¡¼¡×¡Ê»Ê²ñ¡§¿ú¼ÀèÀ¸¡Ë

Âè242²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

Âè242²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ï¾ëÆîÉÂÍý-ÀŲ¬ÉÂÍýSPS¹çƱ¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤È¤·¤Æ, 2012ǯ10·î13Æü(ÅÚÍËÆü),¡¡NTTÅìÆüËÜ´ØÅìɱ¡¤Ë¤Æ³«ºÅ¤µ¤ì8Âê¤Î¾ÉÎãÊó¹ð¤ÈÆÃÊֱ̹餬¤ª¤³¤Ê¤ï¤ì¤Þ¤·¤¿¡£---> SPS-¾ëÆîÉÂÍý½¸Ã̲ñ¤Î¥Ú¡¼¥¸¤Ø°Üư

Âè241²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2012ǯ7·î28Æü¸á¸å1:30¡Á¡¡¡÷ÀŲ¬¸©Ã˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢4³¬²ñµÄ¼¼¡¡7Âê¤Î±éÂ꤬ȯɽ¤µ¤ì¤Þ¤·¤¿¡£

£±¡¥¡ÖÂçÆ°Ì®ÊÛ¶¹ºõ¾É¡×
»°±º¹îÉÒ¡ÊÉ;¾°åÂç´ðÁôǸî·ò¹¯²Ê³Ø¡Ë

£²¡¥¡ÖPrimary splenic diffuse large B cell lymphoma manifesting in red pulp¤È¹Í¤¨¤é¤ì¤ë°ìÎã¡×
벬½ñɧ¡¢ÎëÌÚĬ¿Í¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡1¡Ë¡¢¿ú¼½Õɧ ¡ÊÉ;¾°åÂçÉÂÍý³ØÂè°ì¡Ë

£³¡¥¡Ö¿¿À­·Æ¼¼Í³Íè¤È¹Í¤¨¤é¤ì¤¿¾å¹Ô·ëIJµðÂçÇ´±Õ´â¤Î°ìÎã¡×
¿·°æµÁʸ¡¢´ä²¼¼÷½¨¡ÊÉ;¾°åÂçºÆÀ¸¡¦´¶À÷ÉÂÍý³Ø¡Ë¡¢ÉðÅÄ¡¡¿¿(ƱÂèÆó³°²Ê)

£´¡¥¡ÖÌ®´É¿¯½±¤Î¸«Êý¡¦¹Í¤¨Êý¡½´Î¤¬¤ó¡¢¿Õ¤¬¤ó¡¢¹Ã¾õÁ£¤¬¤ó¤Î·ì´ÉÆâ¿¯ÆþÍͼ°¡½¡×
¿ùÌδ¡ÊÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡Ë

£µ¡¥¡Ö¸ý¹ÐÆðÉô¼ðáç¤Î£±Îã¡×
¿¹¡¡¹°¼ù¡ÊÉ;¾°åÎÅ¥»¥ó¥¿¡¼¡Ë

£¶¡¥¡Öº¸³Ü²¼Á£¼ðáç¤Î°ìÎã¡×
Á𿼸ø½¨¡ÊÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡Ë¡¢Á°Â¿¾¾´î¡ÊË­¶¶»Ô̱ɱ¡¡Ë

£·¡¥¡ÖEncapsulated liver cell tumor¤Î£±Îã¡×
¼¼¡¡ÇîÇ·¡¢ÎëÌÚ¡¡À¿¡¢¿·°æ°ì¼é¡ÊÀŲ¬¸©Î©Áí¹çɱ¡¡Ë¡¢¾®¿ù°Ë»°ÉסÊÉ;¾°åÂçÂèÆóÉÂÍý¡Ë--->¾ÉÎã¤Î¥Ú¡¼¥¸¤ò¤ß¤ë

 

Âè240²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2012ǯ5·î25Æü¸á¸å1:30¡Á¡¡¡÷É;¾»ÔÃϰè¾ðÊ󥻥󥿡¼£³³¬¡¡£µÂê¤Î±éÂ꤬ȯɽ¤µ¤ì¤Þ¤·¤¿¡£

1.¡ÖIgG4¾å¾º¤òȼ¤Ã¤¿ÈéÉæ¤ÈÇ٤Υê¥ó¥ÑÁý¿£À­ÉÂÊѤΣ±Îã¡×
ÇϾ졡Áï¡ÊÉ;¾°å²ÊÂç³ØÉí°É±¡¡Ë

2.¡ÖÇÙ¼ðáç¤Î£²Îã¡×
À¶¿å¿Ê°ì¡¤¹¾²Ïͦ¼ù¡¤Âç·î´²Ïº¡ÊÀ»ÎìÉ;¾É±¡¡Ë¡¡

3.¡Ö¿ÇÃÇ¤ËÆñ½Â¤·¤¿¶»Ëì¼ðáç¤Î£±Îã¡×
ÃæÅç¡¡¹§¡ÊÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡ËEpithelioid inflammatory myofibroblastic sarcoma

4.¡ÖA case of neuroendocrine carcinoma of the male breast¡×
³Þ¸¶ÀµÃË¡¢ÅÄÂåϹ°¡ÊÀŲ¬ÀÖ½½»úɱ¡¡Ë¶Í»³¡¡Í¡ÏÂ¡ÊÆ£ÅÄÊÝ·ò±ÒÀ¸Âç³Ø¡Ë

5.¡Ö¥¿¥â¥­¥·¥Õ¥§¥óÅêÍ¿Æý´â´µ¼Ô¤Ëȯ¾É¤·¤¿ steatohepatitis¡×
¼¼¡¡ÇîÇ·¡¢ÎëÌÚ¡¡À¿¡¢¿·°æ°ì¼é¡¢Ãæ¾åÏÂɧ¡¢¾ïÀôÆ»»Ò¡ÊÀŲ¬¸©Î©Áí¹çɱ¡¡Ë

Âè239²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

Âè239²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤ª¤è¤ÓÂè1²óÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÀìÌçÉÂÍý°åÍÜÀ®¸¦½¤²ñ¡¡2011ǯ12·î3Æü¡ÊÅÚÍËÆü¡Ë¸á¸å1:00¡Á17:00 ÀŲ¬»Ô¥Û¥Æ¥ë¥×¥ê¥ô¥§ÀŲ¬¥¹¥Æ¡¼¥·¥ç¥ó¡¡¾ÉÎã±éÂê2Îã¤È¹Ö±é2Âê

£±¡¥¡ÖÇÙ¼ðáç¤Î1Îã¡×É;¾°åÂçÉí°É±¡ Ê¡ÅèËãͳ-- Mixed squamous cell and glandular papilloma¡¡¾ÉÎã¤Î¥Ú¡¼¥¸¤ò¸«¤ë

£²¡¥¡ÖÂçIJÆâʬÈçºÙ˦´â¤Î£±Îã¡×À»ÎìÉ;¾É±¡ ¹¾²Ïͦ¼ù-- Mixed adenoneuroendocrine carcinoma, large cell type with squamous cell differentiation¡¡¾ÉÎã¤Î¥Ú¡¼¥¸¤ò¸«¤ë

Âè1²óÀìÌçÉÂÍý°åÍÜÀ®¸¦½¤²ñ¹Ö±é¡¡

ÂçIJ¾åÈéÀ­¼ðáç¤ÎÉÂÍý¿ÇÃÇ¡¡½çŷƲÂç³ØÂç³Ø±¡°å³Ø¸¦µæ²Ê¡¡È¬ÈøÎ´»Ë

ÇÙ´â¤ò¤á¤°¤ë¥Û¥Ã¥È¥È¥Ô¥Ã¥¯:(1)ÇÙÁ£´âWHOʬÎà²þÄû¤ò¤á¤°¤Ã¤Æ (2)¿À·ÐÆâʬÈç¼ðáç¤ÎÀ­¼Á¤È¿ÇÃÇ¡¡¤¬¤ó¸¦µæ½ê¡¡ÀÐÀîͺ°ì

 

Âè238²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

Âè238²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ï¾ëÆîÉÂÍý-ÀŲ¬ÉÂÍýSPS¹çƱ¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤È¤·¤Æ, 2011ǯ9·î17Æü(ÅÚÍËÆü),¡¡»°Åç»Ô̱²ñ´Û¤Ë¤Æ³«ºÅͽÄꤵ¤ì6Âê¤Î¾ÉÎãÊó¹ð¤ÈÆÃÊֱ̹餬¤ª¤³¤Ê¤ï¤ì¤Þ¤·¤¿¡£---> SPS-¾ëÆîÉÂÍý½¸Ã̲ñ¤Î¥Ú¡¼¥¸¤Ø°Üư

Âè237²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2011ǯ8·î6Æü(ÅÚ) 13:30-17:00
²ñ¾ì¡§ÀŲ¬¸©Ã˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢4³¬²ñµÄ¼¼

£±¡¥¡ÖCD30-positive thymic well differentiated neuroendocrine carcinoma (carcinoid) ¤Î£±Îã¡× --->¾ÉÎã¤Î¥Ú¡¼¥¸
벬¡¡½ñɧ¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡¡Ë¿ú¼¡¡½Õɧ (É;¾°åÂçÂè°ìÉÂÍý³Ø¹ÖºÂ)

£²¡¥¡ÖLow grade¤Î¹ü¤Îsarcoma¡×
°ËÆ£¡¡°ÊÃÎϺ¡ÊÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡Ëparaosteal osteosarcoma

£³¡¥¡ÖSexcord-stromal tumor (adult granulosa cell tumor, theca cell- fibroblastic tumor, and Sertoli-stromal cell tumor) ¤Î£³¾ÉÎã¡×
³Þ¸¶¡¡ÀµÃË¡¢ÅÄÂ塡Ϲ°¡ÊÀŲ¬ÀÖ½½»úɱ¡¡Ë

£´¡¥¡ÖÂÛÈ×29wÀÚÇ÷ÁỺ¡¢¾ï°ÌÂÛÈ×Áá´üÇíÎ¥¡×
»°±º¡¡¹îÉÒ¡ÊÉ;¾°åÂç´ðÁôǸî·ò¹¯²Ê³Ø¡Ë

£µ¡¥¡ÖEBV´¶À÷¤òȼ¤¦Àü¹¦À­¶õIJÄÙáç¡¢polymorphic lymphoproliferative disorder¡¢82ºÐÃËÀ­¡×
¼¼¡¡ÇîÇ·¡¢ÎëÌÚ¡¡À¿¡¢¿·°æ¡¡°ì¼é¡ÊÀŲ¬¸©Î©Áí¹çɱ¡¡Ë

£¶¡¥¡Ö¿ÇÃÇ¤ËÆñ½Â¤·¤¿¥ê¥ó¥ÑÀáÉÂÊѤΣ±Îã¡×
Ê¡Åè¡¡Ëãͳ¡ÊÉ;¾°åÂçÉí°É±¡¡Ë Diffuse large B-cell lymphoma with a prominent epithelioid response

  • Âè237²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤¬2011ǯ8·î6Æü¡ÊÅÚÍËÆü¡Ë¸á¸å1:30¡Á17:00 ÀŲ¬¸©Ã˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢£´³¬ÆÃÊ̲ñµÄ¼¼¤Ç³«ºÅ¤µ¤ì£¶Âê¤Î±éÂ꤬ȯɽƤÏÀ¤µ¤ì¤Þ¤·¤¿¡£½ªÎ»¸åǼÎòñ¡£

Âè236²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2011ǯ5·î28Æü(ÅÚ) 13:30-17:00
²ñ¾ì¡§É;¾»Ô¡¡É;¾»Ô¾ðÊ󥻥󥿡¼£³³¬²ñµÄ¼¼

1.¡Ö²¼³Ü¼ðáç¤Î°ìÎã¡×--->¾ÉÎã¤Î¥Ú¡¼¥¸
Ê¡Åè Ëãͳ¡ÊÉ;¾°å²ÊÂç³ØÉí°É±¡)

2.¡ÖÀ®½Ïǹ˦´ñ·Á¼ð¤ËÈéÉæÉÕ°´ï¼ðáç¤ò¹çÊ»¤·¤¿°ìÎã¡×--->¾ÉÎã¤Î¥Ú¡¼¥¸
¹¾²Ï ͦ¼ù, À¶¿å¿Ê°ì, Âç·î´²Ïº(À»ÎìÉ;¾É±¡)

3.¡ÖÌçÌ®Êĺɤª¤è¤Ó´ÎÆâÃÀ´É¶¹ºõ, ³ÈÄ¥¤ò¤·¤á¤·¤¿¾åÉôÃÀ´É´â¤Î°ì˶¸¡Îã¡×--->¾ÉÎã¤Î¥Ú¡¼¥¸
벬½ñɧ ¿ú¼½Õɧ¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡)

4.¡ÖǾÆâ¿ȯÀ­Çò¼ÁÉÂÊѤΰìÎã¡×--->¾ÉÎã¤Î¥Ú¡¼¥¸
²Ïºê ½¨ÍÛ (É;¾°å²ÊÂç³ØÂèÆóÉÂÍý)

5.¡Ö±¦Â¦Ç¾¼¼¼ðáç¤Î°ìÎã¡×--->subependymoma of the rt. lateral ventricle ¾ÉÎã¤Î¥Ú¡¼¥¸
¿¹ ¹°¼ù, ¾®ß· µü»Ë (É;¾°åÎÅ¥»¥ó¥¿¡¼)

6.¡Ö磼ð¤ÈµÞÀ­´Î±ê¤È¿ÇÃǤµ¤ì¤¿°ìÎã¡×--->¾ÉÎã¤Î¥Ú¡¼¥¸
¿ú¼ ½Õɧ¡ÊÉ;¾°åÂçÂè°ìÉÂÍý³Ø¹ÖºÂ)

7.¡ÖÊ¢¿åºÙ˦¿Ç¤Çȯ¸«¤µ¤ì¤¿¥Ð¡¼¥­¥Ã¥È¥ê¥ó¥Ñ¼ð¡×--->¾ÉÎã¤Î¥Ú¡¼¥¸
¿·°æ °ì¼é¡ÊÀŲ¬¸©Î©Áí¹çɱ¡)

  • Âè236²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤¬2011ǯ5·î28Æü¡ÊÅÚÍËÆü¡Ë¸á¸å1:30¤«¤éÉ;¾»ÔÃϰè¾ðÊ󥻥󥿡¼¡¦²ñµÄ¼¼¤Ç³«ºÅ¤µ¤ì¤Þ¤·¤¿¡£7Âê¤Î±éÂêȯɽ¤¬¤ª¤³¤Ê¤ï¤ì¤Þ¤·¤¿¡£¤ªÅ·µ¤¤Î°­¤¤Ãæ, ³§¤µ¤ó¤´¤ªÈè¤ìÍͤǤ·¤¿¡£
 

Âè235²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2011ǯ3·î26Æü(Æü)¡¡13:30-17:00
²ñ¾ì¡§ÀŲ¬»Ô, ÀŲ¬¸©Ã˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢¡¡4³¬¡¡ÆÃÊ̲ñµÄ¼¼

1.¡ÖSpindle cell lipoma ¤Î£±Îã¡×¹¾²Ï ͦ¼ù¡ÊÀ»ÎìÉ;¾É±¡¡Ë--->¾ÉÎã¤Î¥Ú¡¼¥¸

2.¡ÖMicropapillary component ¤¬Í¥Àª¤Ç¤¢¤Ã¤¿ÂçIJ´â¤Î°ì¼ê½ÑÎã¡×Á𿼠¸ø½¨¡ÊÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡Ë--->¾ÉÎã¤Î¥Ú¡¼¥¸

3.¡Ö¿À·Ð¾É¾õ¤ò½éȯ¤È¤·¤¿¸Â¶É·¿WegenerÆù²ê¼ð¾É¤Î£±Ë¶¸¡Îã¡×³Þ¸¶ ÀµÃË,¡¡ÅÄÂå Ϲ°¡ÊÀŲ¬ÀÖ½½»úɱ¡¡Ë--->¾ÉÎã¤Î¥Ú¡¼¥¸

¡Ú¹Ö±é¡Û¡¡¡¡ ¡Ö°ß´â¼£ÎÅÊý¿Ë¤Ë´Ø¤ï¤ëÉÂÍý¿ÇÃÇ¡ÝToGA»î¸³¤è¤ê¡Ý¡×
¶¶µÍ¡¡·°¡ÊÃæ³°À½Ìô³ô¼°²ñ¼Ò¥á¥Ç¥£¥«¥ë¥µ¥¤¥¨¥ó¥¹Éô¡Ë14:50¡Á

4.¡Ö°ß°­À­¥ê¥ó¥Ñ¼ð¤Îµ¿¤¤¤Î£±Îã¡×ÌÚ²¼ ¿¿Æà¡ÊÉ;¾°åÂçÉí°É±¡ÉÂÍýÉô) --->lymphomatoid gastropathy ¾ÉÎã¤Î¥Ú¡¼¥¸

5.¡ÖǾ¤Î inflammatory pseudotumor ¤Î£±Îã¡×
ÂçÀРľµ±,¡¡Ã«²¬ ½ñɧ¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡) --->¾ÉÎã¤Î¥Ú¡¼¥¸

  • Âè235²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤¬2011ǯ3·î26Æü, ÀŲ¬»Ô¤¢¤¶¤ì¤¢¤Ë¤Æ³«ºÅ¤µ¤ì¤Þ¤·¤¿¡£5Âê¤Î±éÂêȯɽ¤ÈÃæ³°À½Ìô¤Î°ß´â¤Îher2/neu¸¡ºº¤Ë¤Ä¤¤¤Æ¹Ö±é¤¬¤ª¤³¤Ê¤ï¤ì¤Þ¤·¤¿¡£¸¡Æ¤²ñ½ªÎ»¸åÈØÅÄ»ÔΩɱ¡¸¦½¤°åÂçÀз¯¤ÎÁ÷Ê̲ñ

Âè234²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2011ǯ1·î22Æü(ÅÚ) 13:30-17:00
²ñ¾ì¡§ÀŲ¬»Ô, ÀŲ¬¸©Ã˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢¡¡4³¬¡¡ÆÃÊ̲ñµÄ¼¼

£±¡¥¡Ö£µÇ¯´Ö¤Îç¯æù´â¼£ÎÅÃæ¤ËȯÀ¸¤·¤¿±¢·ÔÉôǢƻ¼ðáç¤Î£±Îã¡×--->¾ÉÎã¤Î¥Ú¡¼¥¸
ÂçÀÐľµ±¡¢Ã«²¬½ñɧ¡¢¿ú¼½Õɧ¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡¡Ë

£²¡¥¡ÖÆñ¼£À­ÄÙáç¤òȼ¤¦°ß¼ðáçÀ­ÉÂÊÑ¡×
¾®¿ù°Ë»°ÉסÊÉ;¾°åÂçÂèÆóÉÂÍý¡Ë

£³¡¥¡Ö¿©Æ»¼ðáç¤Î£±¼ê½ÑÎã¡×
Á𿼸ø½¨¡ÊÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡Ë--->¾ÉÎã¤Î¥Ú¡¼¥¸

£´¡¥¡ÖPTXÅêÍ¿´µ¼Ô¤Ëȯ¾Í¤·¤¿ARDS¡×
¼¼¡¡ÇîÇ·¡¢ÎëÌÚ¡¡À¿¡¢¿·°æ°ì¼é¡ÊÀŲ¬¸©Î©Áí¹çɱ¡¡Ë

£µ¡¥¡ÖÆâʬÈçºÙ˦ͥ°ÌDCIS¡×
»°±º¹îÉÒ¡ÊÉ;¾°åÂç´ðÁôǸî·ò¹¯²Ê³Ø¡Ë

£¶¡¥¡ÖÇÙbasaloid squamous cell carcinoma¤Î£±Ë¶¸¡Îã¡×
Âç·î´²Ïº¡¤À¶¿å¿Ê°ì¡¤¹¾²Ïͦ¼ù¡ÊÀ»ÎìÉ;¾É±¡¡Ë

£·¡¥¡ÖºÇ¶á·Ð¸³¤·¤¿ALKÇٴ⣴Îã¤ÎÁÈ¿¥³ØÅªÆÃħ¡×
ÃæÅç¡¡¹§¡ÊÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼) --->¾ÉÎã¤Î¥Ú¡¼¥¸

 
  • Âè234²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤¬2011ǯ1·î22Æü¡¢ÀŲ¬»Ô¤¢¤¶¤ì¤¢¤Ë¤Æ³«ºÅ¤µ¤ì¤Þ¤·¤¿¡££·Âê¤Î±éÂ꤬ȯɽ¤µ¤ì³èȯ¤ÊƤÏÀ¤¬¤ª¤³¤Ê¤ï¤ì¤Þ¤·¤¿¡£¸¡Æ¤²ñ½ªÎ»¸å¿·Ç¯²ñ¡£JRÀŲ¬±Ø¥Ó¥ëÆâ¤Î¡Öµû²Ï´ßÂçºî¡×

Âè233²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

2010ǯ11·î20Æü(ÅÚ) 13:30-17:00
²ñ¾ì¡§É;¾»ÔÃϰè¾ðÊ󥻥󥿡¼²ñµÄ¼¼

1. ¡ÖµÞÀ­¹ü¿ñÀ­Çò·ìɼ£ÎŤ˽и½¤·¤¿±¦·ÛÉô¼ðáî¤Î1Îã¡×¡¡Áð´Öͳµª»Ò(É;¾°å²ÊÂç³ØÉí°É±¡)--->¾ÉÎã¤Î¥Ú¡¼¥¸¤Ø

2. ¡Ö²õ»àÀ­¶ÚËì±ê¤Î1Îã¡×¡¡ÌÚ²¼¿¿Æà(É;¾°å²ÊÂç³ØÉí°É±¡)--->¾ÉÎã¤Î¥Ú¡¼¥¸

3. ¡Ö12ºÐ½÷»ù¤ÎÆýÁ£¼ðáî¡×¡¡ÉͺêË­, ´äÊ¥±Ñ¿Í, ¹â·¬·ÃÈþ(¸©Î©¤³¤É¤âɱ¡)--->¾ÉÎã¤Î¥Ú¡¼¥¸

4. ¡Ö²óÌÕÉô¼ðáî¤Ç, ¶ÛµÞ¼ê½Ñ¤È¤Ê¤Ã¤¿50ºÐÂåÃËÀ­¡×Á°Â¿¾¾´î(Ë­¶¶»Ô̱ɱ¡)--->¾ÉÎã¤Î¥Ú¡¼¥¸

5. ¡ÖÉû¿ÕÈé¼ÁÁ£¼ð(Cushing¾É¸õ·²),¹Ã¾õÁ£ÆýƬ´â, ç£Â¡¼ðá礪¤è¤ÓÊ¢¹ÐÆâ¿ȯ¼ðáç¤Î1Îã¡×ÇϾìÁï¡ÊÉ;¾°å²ÊÂç³ØÉí°É±¡)

6. ¡ÖDisseminated calcifying tumor of the pleura¤Î1Îã¡×¡¡ÃæÅç¹§(ÀŲ¬¸©Î©¤¬¤ó¥»¥ó¥¿¡¼)--->¾ÉÎã¤Î¥Ú¡¼¥¸¤Ø

7. ¡ÖÇ¥¿±Ãæ¤ÎµÞÀ­Ãî¿â±ê¤Î1Îã¡×¿¹¹°¼ù(¸©À¾ÉôÉ;¾°åÎÅ¥»¥ó¥¿¡¼)---> ¾ÉÎã¤Î¥Ú¡¼¥¸¤Ø

Âè232²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹

Âè232²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ï¾ëÆîÉÂÍý-ÀŲ¬ÉÂÍý°å²ñ¹çƱÉÂÍý½¸Ã̲ñ Johnan SPS Joint Pathology Conference¤È¤Ê¤ê¤Þ¤¹¡£

Âè231²óÀŲ¬ÉÂÍý°å²ñ(SPS)

2010ǯ8·î21Æü(ÅÚ) 13:30-17:00
²ñ¾ì¡§ÀŲ¬»Ô¾¦¹©²ñµÄ½ê3³¬ ²ñµÄ¼¼

£±¡¥¡Öplacental mesenchymal dyplasia ¤Î£²Îã¡×¹¾²Ïͦ¼ù¡¢Âç·î´²Ïº¡¢À¶¿å¿Ê°ì¡ÊÀ»ÎìÉ;¾É±¡) --->¾ÉÎã¤Î¥Ú¡¼¥¸

£²¡¥¡ÖMethotrexate ´ØÏ¢¥ê¥ó¥ÑÁý¿£¼À´µ¤Î£±Îã¡×¿¹ÌÚÍø¾¼¡ÊÀŲ¬»ÔΩÀجɱ¡¡Ë--->¾ÉÎã¤Î¥Ú¡¼¥¸

£³¡¥¡Ö³Ü²¼¥ê¥ó¥ÑÀá¼ðáî¤Î£±Îã¡×ÌÚ²¼¡¡¿¿Æà£±, À±¡¡¾¼Æó2¡Ê1É;¾°åÂçÉÂÍýÉô, 2ÀŲ¬ºÑÀ¸²ñÁí¹çɱ¡¡Ë-->¾ÉÎã¤Î¥Ú¡¼¥¸

£´¡¥¡Ö±¦ÚÕ°öƬ´Ö·ä¼ðáç¤Î£±¼ê½ÑÎã¡×Á𿼠¸ø½¨¡ÊÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡Ë

£µ¡¥¡Ö¿ȯÇÙÆâž°Ü¤ò¹Í¤¨¤¿°Û·¿II·¿¾åÈé²á·ÁÀ®¤òȼ¤¦ÇÙ±ê¤Î£±Îã¡×ÃæÅç¡¡¹§¡ÊÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡Ë

£¶¡¥¡ÖÂçÂܹü¤ª¤è¤Ó¹üÈ×¹ÐȯÀ¸ giant cell tumor with malignant potential ¡Êmalignant fibrous histiocytoma, giant cell type¡Ë ¤Î£²¾ÉÎã¡×
벬½ñɧ£±, ÂçÀÐľµ±£±, ¿ú¼½Õɧ£²¡Ê£±ÈØÅÄ»ÔΩÁí¹çɱ¡, 2É;¾°åÂçÂè°ìÉÂÍý¡Ë

£·¡¥¡Ö²èÁü¤Ç°­À­¤È¤Î´ÕÊ̤Τऺ¤«¤·¤¤ÅüÇ¢ÉÂÀ­¥Þ¥¹¥È¥Ñ¥Á¡¼¤Î£±Îã¡×»°±º¹îÉÒ¡ÊÉ;¾°åÂç·ò¹¯²Ê³Ø¡Ë

£¸¡¥¡ÖÇÙ¼ðáç¤Î£±Ë¶¸¡Îã pulmonary blastoma ¤È¤¹¤Ù¤­¤« carcinosarcoma ¤È¤¹¤Ù¤­¤«¡©¡×¿¹¡¡¹°¼ù¡Ê¸©À¾ÉôÉ;¾°åÎÅ¥»¥ó¥¿?¡Ë

½ªÎ»¸å¡¢¡Ö½½Àé²ÖÁ°¡×¤Ë¤ÆÇ¼Îòñ

±éÂê¾ÉÎã¤ÎÎ×¾²»ö¹à¥×¥ê¥ó¥È´õ˾¤ÎSPS²ñ°÷¤ÎÊý¤Ï---> ¾ÉÎãÎ×¾²»ö¹à¤ò[[¥À¥¦¥ó¥í¡¼¥É:]
¡Ê¥Ñ¥¹¥ï¡¼¥É¤¬É¬ÍפǤ¹¡£¥Ñ¥¹¥ï¡¼¥É¤´´õ˾¤Î²ñ°÷¤Ï¥¿¥¤¥È¥ë¤ò¥Ñ¥¹¥ï¡¼¥É´õ˾¤È¤·¤Æ
wikipathologica@gmail.com¡¡¤Ø¥á¡¼¥ë¤òÁ÷¤Ã¤Æ²¼¤µ¤¤¡£)

  • Âè231²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤¬2010ǯ8·î21Æü(ÅÚ)ÀŲ¬¾¦¹©²ñµÄ½ê²ñ´Û¤Ç³«ºÅ¤µ¤ì¤Þ¤·¤¿¡£8±éÂ꤬ȯɽ¤µ¤ìÇ®¿´¤ÊƤÏÀ¤¬¤ª¤³¤Ê¤ï¤ì¤Þ¤·¤¿¡£²ñ½ªÎ»¸å¤Ë½½Àé²ÖÁ°(ú¾Æ¤­¡¦¤ª¤Ç¤ó)¤ÇǼÎòñ¡£

Âè230²óÀŲ¬ÉÂÍý°å²ñ(SPS)

2010ǯ6·î26Æü(ÅÚ) 13:30- 17:00
²ñ¾ì¡§É;¾»ÔÃϰè¾ðÊ󥻥󥿡¼ 4³¬ ²ñµÄ¼¼

1.¡ÖPapillary fibroelastoma ¤Î£²Îã¡× ¡¡ÂçÀÐ °ìÊ¿£±¡¢¿·Â¼ ÏÂÌ飲¡¢±óÆ£ ͺ»°£²¡¢¿ú¼ ½Õɧ£² ¡Ê1.É;¾°åÂç°å³Ø²Ê£¶Ç¯¡¢2.É;¾°åÂçÂè°ìÉÂÍý³Ø¹ÖºÂ¡Ë

2.¡ÖÈéÉæ¼ðáç¡× ¡¡À¶¿å ¿Ê°ì, ¹¾²Ïͦ¼ù, Âç·î´²Ïº ¡ÊÀ»ÎìÉ;¾É±¡ÉÂÍý²Ê¡Ë

3.¡Ö¥·¥ã¥ó¥È¼À´µ¤¬µ¿¤ï¤ì¤¿¹â¿´Çï½ÐÀ­¿´ÉÔÁ´¤Î£±Ë¶¸¡Îã¡× ¡¡¿¹ÌÚ Íø¾¼ ¡ÊÀŲ¬»ÔΩÀجɱ¡ÉÂÍý²Ê¡Ë

4.¡ÖÍñÁ㡦ʢËì¤ÎɽºßÀ­ÞùËìÀ­ÆýƬ´â(SSPC)¤Î£³Îã¡× ¡¡³Þ¸¶ ÀµÃË¡¢ÅÄÂå Ϲ° ¡ÊÀŲ¬ÀÖ½½»úɱ¡ÉÂÍýÉô¡Ë

5.¡Ö¸å½Ä³Ö¼ðáç¤Î£±Îã¡× ¡¡´äÊ¥ ±Ñ¿Í ¡ÊÀŲ¬¸©Î©¤³¤É¤âɱ¡Î×¾²ÉÂÍý²Ê¡Ë

6.¡Ö°ß¤ÎÄãʬ²½·¿Á£´â¤Ë°ß¸¶È¯ßÉ˦À­¥ê¥ó¥Ñ¼ð¤ò¹çÊ»¤·¤¿£±Îã¡× ¡¡ÃæÂ¼ ±Ù»Ò ¡ÊË­¶¶°åÎÅ¥»¥ó¥¿¡¼Î×¾²¸¡ºº²Ê¡Ë--->¾ÉÎã¤Î¥Ú¡¼¥¸

7.¡ÖÆÃ°Û¤ÊÉô°Ì¤Ëȯ¾É¤·¤¿ extranodal NK/T-cell lymphoma, nasal type ¤Î£±Îã¡× ¡¡¼¼¡¡ÇîÇ·1¡¢ÎëÌÚ¡¡À¿1¡¢¿·°æ °ì¼é1¡¢ÇϾ졡Áï2¡¢²ÃÆ£ ÃÒ¹Ô2 ¡Ê1.ÀŲ¬¸©Î©Áí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¢2.É;¾°åÂçÉÂÍýÉô¡Ë

8.¡Öperforin¤¬ÍÛÀ­¤ò¼¨¤¹Âç·¿°Û·¿ºÙ˦¤Î½Ð¸½¤·¤¿°­À­¥ê¥ó¥Ñ¼ð¤Î°ìÎã¡× ÂçÀС¡Ä¾µ±1¡¤Ã«²¬ ½ñɧ1, ¿ú¼¡¡½Õɧ2(1.ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¢2.É;¾°åÂçÂè°ìÉÂÍý³Ø¹ÖºÂ)

±éÂê¾ÉÎã¤ÎÎ×¾²»ö¹à¥×¥ê¥ó¥È´õ˾¤ÎSPS²ñ°÷¤ÎÊý¤Ï---> ¾ÉÎãÎ×¾²»ö¹à¤ò¥À¥¦¥ó¥í¡¼¥É
¡Ê¥Ñ¥¹¥ï¡¼¥É¤¬É¬ÍפǤ¹¡£¥Ñ¥¹¥ï¡¼¥É¤´´õ˾¤Î²ñ°÷¤Ï¥¿¥¤¥È¥ë¤ò¥Ñ¥¹¥ï¡¼¥É´õ˾¤È¤·¤Æ
wikipathologica@gmail.com¡¡¤Ø¥á¡¼¥ë¤òÁ÷¤Ã¤Æ²¼¤µ¤¤¡£)

Âè229²óÀŲ¬ÉÂÍý°å²ñ(SPS)

2010ǯ4·î17Æü(ÅÚ)¡¡13:30- 17:00
²ñ¾ì¡§ÀŲ¬¸©Ã˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢¡¡4³¬¡¡ÆÃÊ̲ñµÄ¼¼

1.¡¡¡ÖÆù¼ðÀ®Ê¬¤Ë̤ʬ²½¿À·ÐÁÈ¿¥¤òǧ¤á¤ëðôÉôȯÀ¸¤È¹Í¤¨¤é¤ì¤¿»ÒµÜ´âÆù¼ð¤Î°ìÎã¡×
ÂçÀÐľµ±£±, 벬½ñɧ£±, ¿ú¼½Õɧ£²¡Ê1.ÈØÅÄ»ÔΩÁí¹çɱ¡ Î×¾²¸¡ºº²Ê¡¡2.É;¾°å²ÊÂç³ØÉÂÍý³ØÂè°ì¹ÖºÂ) --> Uterine cervical carcinosarcoma with neuroectodermal differentiation, ¾ÉÎã¤Î¥Ú¡¼¥¸

2. ¡ÖÀ¸¸åÁá´ü¤è¤êÆ©ÀϤòɬÍפȤ·¤¿1˶¸¡Îã¡×
¹â¾ì·ÃÈþ¡¤´äÊ¥±Ñ¿Í¡¤Éͺꡡ˭¡ÊÀŲ¬¸©Î©¤³¤É¤âɱ¡ Î×¾²ÉÂÍý²Ê¡Ë--> Renal tubular dysgenesis, ¾ÉÎã¤Î¥Ú¡¼¥¸

3. ¡Ö98ºÐ½÷À­¡¢108ºÐ½÷À­¡¡Ï·¿ÍÀ­¥¢¥ß¥í¥¤¥É¡¼¥·¥¹¤Î2Îã¡×
»°±º¹îÉÒ¡ÊÉ;¾°å²ÊÂç³Ø ·ò¹¯²Ê³Ø¡Ë--> senile amyloidosis, ¾ÉÎã¤Î¥Ú¡¼¥¸

4. ¡Ö·Ðµ¤Æ»À­¿ÊŸ¤ò¼¨¤¹Äãʬ²½ÇÙÁ£´â¤Î°ìÎã¡×
ÃæÅç¡¡¹§ (ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzÊ) --> adenocarcinoma of the lung with diverse histology and progression, ¾ÉÎã¤Î¥Ú¡¼¥¸

5. ¡ÖÃæÉô¿©Æ»Îΰè¤ËȯÀ¸¤·¤¿basalioid carcinoma with adenoid cystic carcinoma fearture ¤Î°ìÎã¡×
³Þ¸¶ÀµÃË¡¢ÅÄÂåϹ°¡¢°ðÅÄ·ò°ì1)¡ÊÀŲ¬ÀÖ½½»úɱ¡ ÉÂÍýÉô¡¡1¡ËÆ£ÅÄÊÝ·ò±ÒÀ¸Âç ³ØÂè°ìÉÂÍý³Ø¶µ¼¼)-->¾ÉÎã¤Î¥Ú¡¼¥¸

6. ¡Ö±¦¼ª²¼Á£°­À­¼ðáç¤Î°ì¼ê½ÑÎã¡×
Á𿼸ø½¨ (ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzÊ) adenosquamous cell carcinoma of the parotid gland, ¾ÉÎã¤Î¥Ú¡¼¥¸

7. ¡ÖľIJ´âÊ¢ËìÇżï¤Îµ¿¤¤¡×
ÇϾ졡Áï¡ÊÉ;¾°å²ÊÂç³ØÉí°É±¡ ÉÂÍýÉô¡Ëdesmoplastic round cell tumor, ¾ÉÎã¤Î¥Ú¡¼¥¸¡¡S¾õ·ëIJÀ¸¸¡ÁÈ¿¥¤«¤é¤Î¿ÇÃÇ.

±éÂê¾ÉÎã¤ÎÎ×¾²»ö¹à¥×¥ê¥ó¥È´õ˾¤ÎSPS²ñ°÷¤ÎÊý¤Ï---> ¾ÉÎãÎ×¾²»ö¹à¤ò¥À¥¦¥ó¥í¡¼¥É
¡Ê¥Ñ¥¹¥ï¡¼¥É¤¬É¬ÍפǤ¹¡£)

Âè228²óÀŲ¬ÉÂÍý°å²ñ(SPS)

2010ǯ2·î27Æü(ÅÚ) 13:30- 17:00
²ñ¾ì¡§ÀŲ¬¸©Ã˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢¡¡4³¬¡¡ÆÃÊ̲ñµÄ¼¼
²ñ½ªÎ»¸å¤ËÉâ·îϰ¤Ç¼¼ÀèÀ¸¤Î¤´Äêǯ°ÖÏ«¤Î±ã¡£

1. ¡ÖUterine tumors resembling ovarian sex cord tumor (UTROSCT) ¤Î°ìÎã¡×
ÂçÀÐľµ±£±, 벬½ñɧ£±, ¿ú¼½Õɧ£²¡Ê1.ÈØÅÄ»ÔΩÁí¹çɱ¡ Î×¾²¸¡ºº²Ê¡¡2.É;¾°å²ÊÂç³ØÉÂÍý³ØÂè°ì¹ÖºÂ¡Ë--->¾ÉÎã¤Î¥Ú¡¼¥¸

2. ¡Ö°ß³êËìÆù¼ð¤Î£±¾ÉÎã¡×
¹¾²Ïͦ¼ù¡¤Âç·î´²Ïº¡¤À¶¿å¿Ê°ì¡¤¾®ÎÓ¡¡´²¡ÊÀ»ÎìÉ;¾É±¡ ÉÂÍý¿ÇÃDzÊ)--->¾ÉÎã¤Î¥Ú¡¼¥¸

3. ¡Ö»ÒµÜ·ÛÉô¥¹¥ê¥¬¥é¥¹ºÙ˦´â¤Î1Îã¡×»°±º¹îÉÒ¡ÊÉ;¾°å²ÊÂç³Ø ·ò¹¯²Ê³Ø)--->¾ÉÎã¤Î¥Ú¡¼¥¸

4. ¡Ö¶»Êɼðáç¤Î£±Îã¡×¿¹ÌÚ Íø¾¼ (ÀŲ¬»ÔΩÀجɱ¡ ÉÂÍý²Ê)--->¾ÉÎã¤Î¥Ú¡¼¥¸

5.¡ÖCD3, CD20, bcl-2 ÌȱÖÀ÷¿§¤ÎÎ×¾²¸¡ººÀºÅÙ´ÉÍýÄ´ººÊó¹ð¡×·ªÅÄ¡¡¾¼¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡ Î×¾²¸¡ºº²Ê)--->ÀºÅÙ´ÉÍý¤Î¥Ú¡¼¥¸

6.¡Ö·ìÀ¶IgG4¹âÃͤò¼¨¤·¤¿¸¶È¯À­¹Å²½À­ÃÀ´É±ê¤Î°ìÎã¡×
¼¼¡¡ÇîÇ·¡¢¿·°æ°ì¼é¡¢ÎëÌÚ¡¡À¿ (ÀŲ¬¸©Î©Áí¹çɱ¡ ÉÂÍý¿ÇÃDzÊ)--->¾ÉÎã¤Î¥Ú¡¼¥¸

7.¡ÖÂçIJ¤ÎÆâʬÈçºÙ˦´â¤Î°ìÎã¡×
ÎëÌÚ¡¡À¿¡¢¿·°æ°ì¼é¡¢¼¼¡¡ÇîÇ· (ÀŲ¬¸©Î©Áí¹çɱ¡ ÉÂÍý¿ÇÃDzÊ)--->¾ÉÎã¤Î¥Ú¡¼¥¸

8. ¡Ö¿§ÁÇÄÀÃå¤òȼ¤Ã¤¿¸ý¹ÐÆâ¼ðáç¤Î°ìÎã¡×
ÌÚ²¼¿¿Æà¡ÊÉ;¾°å²ÊÂç³ØÉí°É±¡ ÉÂÍýÉô¡Ë--->¾ÉÎã¤Î¥Ú¡¼¥¸

9. ¡ÖALKÍÛÀ­ÇÙ´â¤Î4Îã¡×
ÃæÅç¹§(ÀŲ¬¤¬¤ó¥»¥ó¥¿-ÉÂÍý¿ÇÃDzÊ)--->¾ÉÎã¤Î¥Ú¡¼¥¸

±éÂê¾ÉÎã¤ÎÎ×¾²»ö¹à¥×¥ê¥ó¥È´õ˾¤ÎSPS²ñ°÷¤ÎÊý¤Ï---> ¾ÉÎãÎ×¾²»ö¹à¤ò¥À¥¦¥ó¥í¡¼¥É
¡Ê¥Ñ¥¹¥ï¡¼¥É¤¬É¬ÍפǤ¹¡£)

Âè227²óÀŲ¬ÉÂÍý°å²ñ(SPS)

2009ǯ12·î5Æü¡ÊÅÚ¡Ë14:00¡½17:00
²ñ¾ì¡§ÀŲ¬¸©Ã˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢¡¡4³¬¡¡ÆÃÊ̲ñµÄ¼¼

ºÂĹ¡§°ËÆ£ °ÊÃÎϺ¡ÊÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡË

1. ¡Ö±ê¾ÉÀ­¼ðáî¤È´ÕÊ̺¤Æñ¤Êž°ÜÀ­ÇÙ¼ðáî¤ò·ÁÀ®¤·¤¿°ß T-cell lymphoma ¤È¹Í¤¨¤é¤ì¤ë¾ÉÎã¡× 벬 ½ñɧ¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡ Î×¾²¸¡ºº²Ê¡Ë--> ¾ÉÎã¤Î¥Ú¡¼¥¸

2. ¡Ö·ì´É¼þ°ÏÀ­µ¶¥í¥¼¥Ã¥È¤òȼ¤¦Ç¾¼ðáç¤ÈµðÂç¶»¹ÐÆâ¼ðáç¤Î°ìÎã¡× À¾¸¶ ¹°¼£¡Ê»ÔΩÅçÅÄ»Ô̱ɱ¡ ÉÂÍý¿ÇÃDzʡË

3. ¡Ö¿ÇÃÇ¤Î¶Ë¤á¤ÆÆñ¤·¤«¤Ã¤¿¾®»ù¤ÎËËÉôÆðÉô¼ðáç¤Î1Îã¡× »°±º ¹îÉÒ¡ÊÉ;¾°å²ÊÂç³Ø ´ðÁôǸî·ò¹¯²Ê³Ø¡Ë

4. ¡ÖParacoccidioidomycosis¡×¤Î1Îã¡× ÃæÅç ¹§¡ÊÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡË

ºÂĹ¡§ÃæÅç ¹§¡ÊÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡË

5. ¡ÖËܱ¡¤Ç·Ð¸³¤·¤¨¤¿Èæ³ÓŪµ©¤ÊÆý´â¤Î2¾ÉÎã¡× ³Þ¸¶ ÀµÃË¡ÊÀŲ¬ÀÖ½½»úɱ¡ ÉÂÍýÉô¡Ë

6. ¡ÖPseudomyxoma peritonei ¤Î1Îã¡× ÎëÌÚ À¿¡ÊÀŲ¬¸©Î©Áí¹çɱ¡ ÉÂÍý¿ÇÃDzʡË

7. ¡ÖǾ¼¼´â¤Î1Îã¡× ¼¼ ÇîÇ· (ÀŲ¬¸©Î©Áí¹çɱ¡ ÉÂÍý¿ÇÃDzÊ)

8.¡Ö·ÛÉô¥ê¥ó¥ÑÀá¼ðáç¤Î1Îã¡× ¾®¿ù °Ë»°ÉסÊÉ;¾°å²ÊÂç³Ø ÉÂÍý³ØÂèÆó¹ÖºÂ)--->CD4+,CD56+ Hematodermal tumor, ¼À´µ²òÀâ¤È¾ÉÎã

Âè226²óÀŲ¬ÉÂÍý°å²ñ(SPS)

Âè226²ó¤ÏSPS¡¦¾ëÆîÉÂÍý½¸Ã̲ñ¤È¤Ê¤ê¤Þ¤¹¡£¡¡2009ǯ9·î27Æü(ÅÚ) -->»°Åç»ÔÅì¥ì¸¦½¤¥»¥ó¥¿--> SPS-¾ëÆîÉÂÍý½¸Ã̲ñ¤Î¥Ú¡¼¥¸¤Ø

Âè225²óÀŲ¬ÉÂÍý°å²ñ(SPS)

2009ǯ7·î4Æü¡¡ÀŲ¬»Ô¤¢¤¶¤ì¤¢Ã˽÷»²²è¶¦Æ±¥»¥ó¥¿¡¼Â¿ÌÜŪ¼¼ ¡¡²ñ½ªÎ»¸åǼÎòñ¡÷¶äºÂ¥é¥¤¥ª¥ó

1. ¡Ö¸åÊ¢ËìImmature teratoma¤ò½éȯ¾É¾õ¤È¤·¤¿ÀºÁãmixed germ cell tumor¤Î£±Îã¡×ÂçÀРľµ±¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡ Î×¾²¸¡ºº²ÊÉÂÍý¡Ë--->¼À´µ²òÀâ¤È¾ÉÎã

2. ¡Ö£·ºÐÃË»ù¡¡Â裴Ǿ¼¼¼ðáç ¡×»°±º ¹îÉÒ¡ÊÉ;¾°å²ÊÂç³Ø ´ðÁôǸî·ò¹¯²Ê³Ø¡Ë-->[[¼À´µ²òÀâ¤È¾ÉÎã>SPS225-Case02;

3. ¡Ö¹ü¿ñ°Ü¿¢¸åÁá´ü¤ËÃ×»àŪ¤ÊÇÙÉÂÊѤòÍ褷¤¿£±Îã¡×¹â¾ì ·ÃÈþ¡ÊÀŲ¬¸©Î©¤³¤É¤âɱ¡ Î×¾²ÉÂÍý²Ê¡Ë-->[[¼À´µ²òÀâ¤È¾ÉÎã>SPS225-Case03

4. ¡Ö±¦·ÛÉô¼ðáî¤Î£±Îã¡×¿¹ÌÚ Íø¾¼ (ÀŲ¬»ÔΩÀجɱ¡ ÉÂÍý²Ê)-->[[¼À´µ²òÀâ¤È¾ÉÎã>SPS225-Case04;

5. ¡ÖÀÅÌ®¹Å²½¾É¤Ë¤è¤ëµõ·ìÀ­Ä²±ê¤Î£±Îã¡×³Þ¸¶¡¡ÀµÃË¡ÊÀŲ¬ÀÖ½½»úɱ¡ ÉÂÍýÉô¡Ë--¼À´µ²òÀâ¤È¾ÉÎã

6. ¡Ö±¦ÇÙ¼ðáî (ÂèÆóÊó)¡×ÎëÌÚ¡¡À¿¡ÊÀŲ¬¸©Î©Áí¹çɱ¡ ÉÂÍý¸¡ºº²Ê¡Ë--->[[¼À´µ²òÀâ¤È¾ÉÎã>SPS225-Case06

7. ¡Ö±¦É¨¾åÉôÈé²¼¼ðáî¤Î£±Îã¡×Ìܹõ »Ë¿¥ (É;¾°å²ÊÂç³Ø ÉÂÍýÉô)--->¼À´µ²òÀâ¤È¾ÉÎã

Âè224²óÀŲ¬ÉÂÍý°å²ñ(SPS)

2009ǯ4·î11Æü¡¡É;¾»ÔÃϰè¾ðÊ󥻥ó¥¿-²ñµÄ¼¼

1. ¡Ö±¦ÇÙ¼ðáî¡×ÎëÌÚ¡¡À¿¡ÊÀŲ¬¸©Î©Áí¹çɱ¡ ÉÂÍý¸¡ºº²Ê¡Ë--->Î×¾²»ö¹à¡¦ÉÂÍý½ê¸«

2. ¡Ö¥ê¥ó¥ÑÀáÀü»ÉµÛ°úºÙ˦¿Ç¤Ë¤Æ Äãʬ²½´âž°Ü¤È¤Î´ÕÊÌ¿ÇÃÇ¤ËÆñ½Â¤·¤¿£±Îã¡×µÌ¡¡½¼¹°¡Ê»ÔΩÅçÅÄ»Ô̱ɱ¡ Î×¾²ÉÂÍý²Ê¡Ë--->Î×¾²»ö¹à¡¦ÉÂÍý½ê¸«

3. ¡Ö¸åȯÇÙž°Ü¤òÍ褷¤¿±¦¾å³Ü¼ðáç¤Î°ìÎã¡×Á𿼠¸ø½¨¡¢ÅÏî´ Îï»Ò¡¢°ËÆ£°ÊÃÎϺ¡¢ÃæÅç¡¡¹§¡ÊÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡË--->Î×¾²»ö¹à¡¦ÉÂÍý½ê¸«

4. ¡Öº¸¾åÏÓ¹ü¼ðáç¡×¿¹ÌÚ Íø¾¼ (ÀŲ¬»ÔΩÀجɱ¡ ÉÂÍý²Ê)--->Î×¾²»ö¹à¡¦ÉÂÍý½ê¸«

5. ¡ÖÆýÁ£¥ê¥ó¥ÑÁý¿£À­¼À´µ¤Î°ìÎã¡×¾¾±Æ ¾¼°ì¡¢ºç¸¶ °½»Ò¡¢Á°Â¿ ¾¾´î¡ÊË­¶¶»Ô̱ɱ¡ Î×¾²ÉÂÍý²Ê¡Ë--->Î×¾²»ö¹à¡¦ÉÂÍý½ê¸«

6.¡ÖºÇ¶á¤ÎÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¤Ë¤ª¤±¤ë¡¤PNET¤ª¤è¤Ó¤½¤ÎÎà±ï¼À´µ¤Î¿ÇÃǤˤĤ¤¤Æ¡×ÅÏî´ Îï»Ò¡ÊÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡË--->Î×¾²»ö¹à¡¦ÉÂÍý½ê¸«

7.¡ÖǾ¼ðáç¤Î1Îã¡×²Ïºê ½¨ÍÛ (É;¾°å²ÊÂç³Ø ÉÂÍý³ØÂèÆó¹ÖºÂ)--->Î×¾²»ö¹à¡¦ÉÂÍý½ê¸«

8.¡ÖÆðÉô¼ðá磲Îã ¤½¤Î¸å¡×¿¹¡¡¹°¼ù¡ÊÉ;¾°å²ÊÂç³Ø ÉÂÍý³ØÂè°ì¹ÖºÂ¡Ë---Î×¾²»ö¹à¡¦ÉÂÍý½ê¸«

±éÂê¾ÉÎã¤ÎÎ×¾²»ö¹à¥×¥ê¥ó¥È´õ˾¤ÎSPS²ñ°÷¤ÎÊý¤Ï---> ¾ÉÎãÎ×¾²»ö¹à¤ò¥À¥¦¥ó¥í¡¼¥É
¡Ê¥Ñ¥¹¥ï¡¼¥É¤¬É¬ÍפǤ¹¡£)

Âè223²óÀŲ¬ÉÂÍý°å²ñ(SPS)

2009ǯ1·î31Æü¡¡ÀŲ¬»ÔΩɱ¡¡¡²ñ½ªÎ»¸åŽ¢¤Ò¤³¤ÍŽ£¤Ç¿·Ç¯²ñ

1.¡ÖÁ´¿È¥ê¥ó¥ÑÀá¼ðÂç¤ò¤­¤¿¤·¤¿°ì¾ÉÎã¡×Ë­¶¶»Ô̱ɱ¡Î×¾²ÉÂÍý²Ê¡¡¾¾±Æ¾¼°ì, ºç¸¶°½»Ò, Á°Â¿¾¾´î--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

2.¡Öº¸³Û²¼Éô¼ðáç¤Î°ìÎã¡×ÀŲ¬¸©Î©¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzʡ¡Á𿼸ø½¨--->Î×¾²»ö¹à¡¦ÉÂÍýÁÈ¿¥½ê¸«

3.¡ÖÌȱÖÉÔÁ´¾õÂ֤ˤª¤±¤ëǾǿáç¤ÈÈ鲼ǿáç¤Î2Îã¡×É;¾°åÂçɱ¡ÉÂÍýÉô¡¡Ìܹõ»Ë¿¥--->Î×¾²»ö¹à¡¦ÉÂÍýÁÈ¿¥½ê¸«

4.¡ÖÇ٤˻¶ÉÛÀ­Å¾°Ü¤ò¤­¤¿¤·¤¿»ÒµÜ¶Ú¼ð¤Î1Îã¡×ÀŲ¬¸©Î©Áí¹çɱ¡¡¡¼¼ÇîÇ·, ¿·°æ°ì¼é, ÎëÌÚÀ¿--->

5.¡Ö¿ÇÃÇ¤ËÆñ½Â¤·¤¿ðùγµåÆù¼ð¤Î1Îã¡×ÀŲ¬ÀÖ½½»úɱ¡ÉÂÍýÉô¡¡³Þ¸¶ÀµÃË--->Î×¾²»ö¹à¡¦ÉÂÍýÁÈ¿¥½ê¸«

6.¡Ö³Ü´ØÀáÆð¹ü¼ð¤Îµ¿¤¤¡×É;¾°åÂç·ò¹¯²Ê³Ø¡¡»°±º¹îÉÒ--->

7.¡ÖµðÂç¸åÊ¢Ëì¼ðáî¤Î°ìÎã¡×¤ª¤è¤Ó¡ÖÂçÂÜÆðÉô¼ðáç¤Î°ìÎã¡×É;¾°åÂçÂè°ìÉÂÍý ¿¹¹°¼ù--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

±éÂê¾ÉÎã¤ÎÎ×¾²»ö¹à¥×¥ê¥ó¥È´õ˾¤ÎSPS²ñ°÷¤ÎÊý¤Ï---> ¾ÉÎãÎ×¾²»ö¹à¤ò¥À¥¦¥ó¥í¡¼¥É
¡Ê¥Ñ¥¹¥ï¡¼¥É¤¬É¬ÍפǤ¹¡£wikipathologica@gmail.com¡¡¤Ømail¤·¤Æ²¼¤µ¤¤¡£ÀÞ¤êÊÖ¤·¥Ñ¥¹¥ï¡¼¥É¤ò¤ªÁ÷¤ê¤·¤Þ¤¹¡£)

Âè222²óÀŲ¬ÉÂÍý°å²ñ(SPS)

2008ǯ11·î29Æü¡¡É;¾»ÔÁí¹çÄ£¼Ë

1.Ž¢Æý»ù¤Ëȯ¾É¤·¤¿¼ãǯ·¿ðùγËìºÙ˦¼ðŽ£¡¡ÀŲ¬¸©Î©¤³¤É¤âɱ¡¡¡ÉÂÍý¡¡¹â¾ì·ÃÈþ, ÉͺêË­--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

2.Ž¢±¦¼ª²¼Á£¼ðáç¤Î°ìÎ㎣¡¡ÀŲ¬¸©Î©¤¬¤ó¥»¥ó¥¿- ÉÂÍý¿ÇÃDzʡ¡Á𿼸ø½¨--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

3.Ž¢Clostridium sordelli¤Ë¤è¤ëµÞÀ­Ê¢Ëì±ê¤Î1˶¸¡Î㎣ ¿º¸¶Áí¹çɱ¡¡¡ÉÂÍý¿ÇÃDzʡ¡À¾¸¶¹°¼£--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

4.Ž¢ÇÙ¥ê¥ó¥ÑÌ®´É¶Ú¼ð¾É¤Î1Î㎣¡¡À»ÎìÉ;¾É±¡¡¡ÉÂÍý¿ÇÃDzʡ¡¹¾²Ïͦ¼ù--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

5.Ž¢sCD3±¢À­ Blastic NK/T neoplasm¤Î1Î㎣¡¡ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡¡ÉÂÍý¿ÇÃDzʡ¡ÅÏî´Îï»Ò--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

6.Ž¢Primary cutaneous follicle center lymphoma¤Î°ìÎã- ÈéÉæ¤«¤é¤Î¿ÊŸÎã?Ž£ ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¡¡Ã«²¬½ñɧ--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

7.Ž¢¼«Á³ÇËÎö¤¬µ¿¤ï¤ì¤¿20ºÐÂåÃËÀ­¤Îmulticystic nephroma(multilobular cystic nephroma, multilocular cyst)¤Î˶¸¡Î㎣¡¡ÀŲ¬ÆüÀÖɱ¡¡¡ÉÂÍýÉô¡¡³Þ¸¶ÀµÃË--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

8.Ž¢¥¯¥í¥¦¡¦¥Õ¥«¥»¡¡Crow-Fukase¾É¸õ·²(POEMS¾É¸õ·², ¹â·îÉÂ)¤Î°ìÎ㎣¡¡Ë­¶¶»Ô̱ɱ¡¡¡Î×¾²ÉÂÍý²Ê¡¡Á°Â¿¾¾´î--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

9.Ž¢°ß´â¡¦ÇÙ¹â·ì°µ¾É¤Î˶¸¡Î㎣¡¡É;¾°åÂçÂèÆóÉÂÍý¡¡¾®¿ù°Ë»°É×--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

Êó¹ð Ž¢Ê¿À®20ǯÅÙÀŲ¬¸©Î×¾²¸¡ººÀºÅÙ´ÉÍýÄ´ºº¡¡ÉÂÍý¸¡ººÌȱÖÀ÷¿§¥µ¡¼¥Ù¥¤¤Ë´Ø¤¹¤ë½¸·×¡¦²òÀÏ·ë²ÌŽ£ ÈØÅÄ»ÔΩÁí¹çɱ¡¡¡Î×¾²¸¡ºº²Ê¡¡·ªÅÄ¡¡¾¼

ER, PgRÀ÷¿§·ë²ÌVirtual Slide¤ò¸«¤ë

Âè221²óÀŲ¬ÉÂÍý°å²ñ(SPS)

Âè221²ó¤ÏSPS¡¦¾ëÆîÉÂÍý½¸Ã̲ñ¤È¤Ê¤ê¤Þ¤¹¡£¡¡2008ǯ9·î27Æü(ÅÚ) ¾¼ÏÂÂç³ØÉ±¡Î×¾²¹ÖƲ¡¡¡Ê¾¼ÏÂÂç³ØÉ±¡Æþ±¡ÅïÃϲ¼£±³¬¡Ë--> SPS-¾ëÆîÉÂÍý½¸Ã̲ñ¤Î¥Ú¡¼¥¸¤Ø

Âè220²óÀŲ¬ÉÂÍý°å²ñ(SPS)

2008ǯ6·î21ÆüÉ;¾»ÔÉ;¾¤Þ¤Á¤Å¤¯¤ê¥»¥ó¥¿¡¼

1.¡Ö°ß´â¤Ëʸ¤·¤¿¥ê¥ó¥ÑÁý¿£À­ÉÂÊÑ¡×À»ÎìÉ;¾É±¡¡¡¹¾²Ïͦ¼ù¡¢À¶¿å ¿Ê°ì---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

2.¡ÖÂ軰Ǿ¼¼²¼Éôǹ˦À­¼ðáî¡×ÀŲ¬¸©Î©¤³¤É¤âɱ¡¡¡¹â¾ì·ÃÈþ¡¢Éͺê Ë­---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

3.¡Öç´Ç´Ëì²¼¼ðáç--ç´È¯À¸¤ÎGIST¡×ÀŲ¬»ÔΩÀجɱ¡ ¿¹ÌÚÍø¾¼---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

4.¡Ö±¦Æð¸ý³¸¼ðáç¤Î°ìÎã¡×ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡¡Á𿼸ø½¨---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

5.¡ÖIntervention ¸å¤ËȯÀ¸¤·¤¿¿´¶Ú¾É¤Î£±Ë¶¸¡Îã¡¢£·£´ºÐÃËÀ­¡×ÀŲ¬¸©Î©Áí¹çɱ¡¡¡¼¼¡¡ÇîÇ·¡¢ÎëÌÚ¡¡À¿¡¢¿·°æ°ì¼é---->Î×¾²»ö¹à¡¦¾ÉÎã²òÀâ

6.¡Ö±¦Â¦Ê¢ÊÉ¡¢¾åÉô¸åÊ¢Ëì¡¢¹üÈ׹Ф«¤éÊ¢¹Ð¤Ë¸ºß¤¹¤ëµðÂç¼ðáç¤Î£³¾ÉÎã¡×ÀŲ¬ÀÖ½½»úɱ¡¡¡³Þ¸¶ÀµÃË---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

7.¡Ö²¼¿âÂμðáç¤Î£±Îã¡×É;¾°å²ÊÂç³ØÉí°É±¡¡¡ÌÚ²¼¿¿Æà---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

8.¡ÖÂ軰Ǿ¼¼¼ðáç¤Î£±Îã¡×É;¾°å²ÊÂç³ØÉí°É±¡¡¡Ìܹõ»Ë¿¥---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

Âè219²óÀŲ¬ÉÂÍý°å²ñ(SPS)

2008ǯ3·î22ÆüÀŲ¬»Ô¤¢¤¶¤ì¤¢¤Ç³«ºÅ. ²ñ½ªÎ»¸å,É;¾°åÂçÂèÆóÉÂÍýÅû°æÀèÀ¸¤ÎÂà´±µ­Ç°º©¿Æ²ñ@Éâ·îϰ

£±¡¥°ß´âÆù¼ð¤Î°ìÎã¡¡É;¾°åÂçɱ¡ÉÂÍýÉô¡¡Ìܹõ»Ë¿¥Â¾---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

£²¡¥¿ÇÃǤ˶ìθ¤·¤¿À®¿Í½÷À­Â¦Æ¬ÍÕǾ¼ðáç¤Î°ìÎã¡¡¡¡ÀŲ¬´â¥»¥ó¥¿ÉÂÍý¿ÇÃDzʡ¡ÅÏî´Îï»Ò---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

£³¡¥Å¾°Ü¤«¸¶È¯¤«¤¬ÌäÂê¤È¤Ê¤Ã¤¿83ºÐ½÷À­,ÍñÁã¼ðáç¡¡ÀŲ¬´â¥»¥ó¥¿ÉÂÍý¿ÇÃDzʡ¡ÅÏî´Îï»Ò---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

ÆÃÊ̵­Ç°¹Ö±é¡¡É;¾°åÂçÂèÆóÉÂÍý¶µ¼ø¡¡Åû°æ¡¡¾ÍÇî¡¡

£´¡¥º¸³Ü²¼ÀþÉô¼ðáç¤Î°ìÎã¡¡ÀŲ¬´â¥»¥ó¥¿ÉÂÍý¿ÇÃDzʡ¡Á𿼸ø½¨Â¾---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

£µ¡¥½ÑÁ°TAE¤ò»Ü¹Ô¤·¤¿»éËÃÍÍ·ì´É³°Èé¼ð¤Î°ìÎã¡¡ÀŲ¬ÀÖ½½»úɱ¡ÉÂÍý¡¡³Þ¸¶¡¡ÀµÃË---->¾ÉÎã²òÀâ

£¶¡¥±ó°Ì·¿¥ß¥ª¥Ñ¥·¡¼¤Î°ì˶¸¡Îã¡¡É;¾°åÂçɱ¡ÉÂÍýÉô¡¡ÌÚ²¼¿¿Æà¾---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

Âè218²óÀŲ¬ÉÂÍý°å²ñ(SPS)

2008ǯ1·î26ÆüÉ;¾»ÔÃϰè¾ðÊ󥻥󥿤dz«ºÅ. ²ñ½ªÎ»¸å¿·Ç¯²ñ¡÷¤¢¤ó¤É¤ê¤å¡¼¤¹Äâ

£±¡¥EBVÍÛÀ­¤ò¼¨¤·¤¿ÇÙ·ëÀáÀ­ÉÂÊѤÎ1Îã¡¡É;¾°åÂçÂèÆóÉÂÍý¡¡¿·°æµÁʸ¾---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

£²¡¥±¦Äǹüư̮²òÎ¥À­Æ°Ì®ÇËÎö¤Î1˶¸¡Îã¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡¡¡Ã«²¬½ñɧ¾---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

£³¡¥¿´Ëì°­À­¼ðáç¤Î˶¸¡Îã¡¡ÀŲ¬»ÔΩɱ¡¡¡¿¹ÌÚÍø¾¼---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

£´¡¥µÞÀ­²õ»àÀ­¹¥»ÀµåÀ­¿´¶Ú±ê¤Î1Îã¡¡À»ÎìÉ;¾É±¡¡¡Âç·î´²ÏºÂ¾---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

£µ¡¥ÈéÉæÂå¼ÕÀ­¼À´µ¤Î2Îã¤ÈÈéÉæ±ê¾ÉÀ­¼À´µ¤Î1Îã¡¡ÀŲ¬ÀÖ½½»úɱ¡¡¡³Þ¸¶ÀµÃË--->¾ÉÎã²òÀâ

£¶¡¥ÈéÉæÈóÄê·¿À­¹³»À¶Ý¾É¤Î1Îã¡¡ÀŲ¬¸©Î©Áí¹çɱ¡¡¡¼¼ÇîÇ·--->¾ÉÎã²òÀâ

Âè217²óÀŲ¬ÉÂÍý°å²ñ(SPS)

Âè217²óSPS¤ÏSPS-¾ëÆîÉÂÍý¹çƱ½¸Ã̲ñ¤È¤Ê¤Ã¤Æ¤¤¤Þ¤¹¡£¡¡2007ǯ9·î29Æü(ÅÚ)--> SPS-¾ëÆîÉÂÍý½¸Ã̲ñ¤Î¥Ú¡¼¥¸¤Ø

 

Âè216²óÀŲ¬ÉÂÍý°å²ñ(SPS)

2007ǯ4·î14ÆüÀŲ¬»Ô¤¢¤¶¤ì¤¢¤Ç³«ºÅ. ²ñ½ªÎ»¸åÉâ·îϰ¤ÇÉͺêÀèÀ¸¤Î°ÖÏ«²ñ

  1. Ž¢Ovarian carcinoid¤Î°ìÎ㎣--ovarian carcinoid É;¾°åÂçÉÂÍý³ØÂè°ì¹ÖºÂ¡¡²ÆÌܹ¨»Ò---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«
     
  2. À¸¸¡¤Ç¤ÏÆù²ê¼ðÀ­±ê¾É½ê¸«¤Î¤ß¤Ç¤¢¤Ã¤¿Ù¨Åíperipheral T cell lymphoma¤Î°ìÎã
    peripheral T cell lymphoma unspecified ÈØÅÄ»ÔΩÁí¹çɱ¡¡¡Ã«²¬½ñɧ--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«
     
  3. ¸åÊ¢Ëì¼ðáç---ÃÙȯÀ­ºÆÈ¯ðùγËìºÙ˦¼ð¡¡¿º¸¶Áí¹çɱ¡¡¡À¾¸¶¹°¼£--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«
     
  4. Ž¢¿´Ëì°­À­ÃæÈé¼ð¤È¹Í¤¨¤é¤ì¤¿Ë¶¸¡Î㎣--½Ä³ÖȯÀ¸´âÆù¼ð? ÀŲ¬»ÔΩɱ¡¡¡¿¹ÌÚÍøÌÀ--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«
     
  5. Ž¢º¸Àå²¼¼ðá玣---adenocarcinoma, not otherwise specific ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¡Á𿼸ø½¨--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«
     
  6. Ê¢Ëì¼ðáî¤Ç»ØÅ¦¤µ¤ì¤¿dirofilariasis(¸¤»å¾õÃî¾É)¤Î°ìÎã ÀŲ¬ÀÖ½½»úɱ¡¡¡³Þ¸¶ÀµÃË
    Darie's disease¤Î°ìÎã¡¡¡¡ÀŲ¬ÀÖ½½»úɱ¡¡¡³Þ¸¶ÀµÃË--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«

¹Ö±é ºÂĹ¡§»°±º¹îÉÒ¡¡¡ÊÉ;¾°åÂç´ðÁôǸî¡Ë

Ž¢2005ǯ²þƤGleasonʬÎà¤ÈÌ©Éõ¾®Àþ¸»¤Ë¤è¤ëÁ°Î©Á£´âÆâ¾È¼ÍÎÅË¡Ž£¡¡¼¼ÇîÇ·(ÀŲ¬¸©Î©Áí¹çɱ¡¡Ë

Ž¢¿À·Ð²ê¼ð¤Î¿ÍÍÀ­Ž£¡¡ÉͺêË­(ÀŲ¬¸©Î©¤³¤É¤âɱ¡¡Ë

Âè215²óÀŲ¬ÉÂÍý°å²ñ(SPS)

2007ǯ1·î13Æü(ÅÚ)É;¾¥¢¥¯¥È¸¦½¤¸òή¥»¥ó¥¿¡¼¤Ç³«ºÅ¡£¤½¤Î¸åº©¿Æ²ñ

  1. ·ëIJ´ÖËì¼ðáç¤Î°ìÎã--malignant mesothelioma (60ºÐÂå½÷À­) ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¡Á𿼸ø½¨--->Î×¾²»ö¹à¡¦ÁÈ¿¥Áü
     
  2. ÂçÌÖIJ´ÖËì¤Ë»¶ºß¤¹¤ë·ëÀá¾õ¤Î¹Ã¾õÁ£ÁÈ¿¥--peritoneal strumosis(50ºÐÂå½÷À­)
    ÀŲ¬»ÔΩɱ¡¡¡¿¹ÌÚÍøÌÀ ==>Î×¾²·Ð²á¡¦ÁÈ¿¥Áü
     
  3. Ê¢Ëì´â¤Î°ìÎã--primary serous papillary carcinoma of the peritoneum(70ºÐÂå½÷À­)
    ÀŲ¬¸©Î©Áí¹çɱ¡¡¡¼¼ÇîÇ·
     
  4. ¸å´üÇ¥¿±»ÒµÜÆâËì¤Ë¤ª¤±¤ëÆâ°øÀ­¥Ó¥ª¥Á¥ó¤Î¹âÉÑÅÙ¸¡½Ð É;¾°å²ÊÂç³ØÂèÆóÉÂÍý¡¡²Ïºê½¨ÍÛ==>»ñÎÁ
    ¢ªIntranuclear biotin Lancet. 2004 Aug 7-13;364(9433):532.
     
  5. Muchinous carcinomaÀ®Ê¬¤ò´Þ¤à´Î´â¤Î°ì˶¸¡Îã--combined hepatocellular and cholangiocarcinoma(80ºÐÂåÃËÀ­)
    É;¾°å²ÊÂç³ØÂè°ìÉÂÍý ¿¹¡¡¹°¼ù==>Î×¾²»ö¹à¡¦ÁÈ¿¥Áü
     
  6. º¸°ßư̮ư̮áîÇËÎö¤Ê¤ÉÃæ·¿¶ÚÀ­Æ°Ì®ÉÂÊѤÎÃøÌÀ¤ÊMPO-ANCA´ØÏ¢·ì´É±ê¤Î°ì˶¸¡Îã(70ºÐÂåÃËÀ­)
    ÈØÅÄ»ÔΩÁí¹çɱ¡¡¡Ã«²¬½ñɧ ==> Î×¾²»ö¹à¡¦¥ìÀþ¡¦ÁÈ¿¥²èÁü
     
  7. 30ºÐÂå½÷À­¿Õ¼ðáç--¥ì¥Ë¥ó»ºÀ¸¼ðáç(30ºÐÂå½÷À­)¡¡À»ÎìÉ;¾É±¡¡¡À¶¿å¿Ê°ì==>Î×¾²·Ð²á,¥Þ¥¯¥í,ÁÈ¿¥Áü
     
  8. ¥¤¥ì¥¦¥¹¤Çȯ¾É¤·¤¿°­À­¥ê¥ó¥Ñ¼ð--anaplastic large cell lymphoma ALK+(10ºÐÂåÃË»Ò)
    ÀŲ¬¸©Î©¤³¤É¤âɱ¡¡¡¹â¾ì·ÃÈþ ===> Î×¾²»ö¹à¡¦ÁÈ¿¥Áü
     
  9. ±¦Â¦Àºº÷¾åÂμðáç¤Î°ìÎã--IJ´É¥Ø¥ë¥Ë¥¢¤«¤ó¤È¤ó(70ºÐÂåÃËÀ­)
    º¸Â¦ÂçÂÜÉôÆðÉô¼ðáî--myopericytoma(80ºÐÂåÃËÀ­)
    Ê¢ÉôµðÂç¼ðáî¤ò·ÁÀ®¤·¤¿°­À­¥ê¥ó¥Ñ¼ð--Diffuse large cell lymphoma and variant
    (50ºÐÂå½÷À­)
    ÀŲ¬ÀÖ½½»úɱ¡¡¡³Þ¸¶ÀµÃË¡¡===>Î×¾²»ö¹à¡¦ÁÈ¿¥Áü

Web¥Ö¥é¥¦¥¶(Firefox, sleipnir,Internet Explorer¤Ê¤É¡Ë¤ÇÀŲ¬ÉÂÍý°å²ñ¤ÎVS¤ò¸«¤ëÊýË¡

SPS¤ÎVirtual slide¤ò¸«¤ë===>ÈØÅÄVS¥µ¡¼¥Ð''

  • ½é¤á¤Æ¥¹¥é¥¤¥É¤ò±ÜÍ÷¤¹¤ë¤«¤¿¤Ïɬ¤º===>¤³¤Î¥Ú¡¼¥¸¤ò»²¾È¤·¤Æ¤¯¤À¤µ¤¤

Virtual Slide viewer soft¤Îinstall--->¤³¤Á¤é
½é¤á¤Æ±ÜÍ÷¤¹¤ë¤È¤­¤Ë¤ÏMicrosoft¤ÎIE¤ò»È¤Ã¤Æ¤¯¤À¤µ¤¤¡£Â¾¤Î¥Ö¥é¥¦¥¶¤Ç¤Ï¤¦¤Þ¤¯¥¤¥ó¥¹¥È¡¼¥ë¤¬¤Ç¤­¤Ê¤¤¤è¤¦¤Ç¤¹¡£°ìÅÙ¥¤¥ó¥¹¥È¡¼¥ë¤¹¤ë¤ÈFirefox¤Ê¤É¾¤Î¥Ö¥é¥¦¥¶¤Ç¤âÌäÂê¤Ê¤¯¤ß¤é¤ì¤Þ¤¹
¡Ê±ÜÍ÷¥½¥Õ¥È¤Ï¸½ºßWindows¤Î¤ßÂбþ¤Ç¤¹¡£Mac, Linux¤Ë¤ÏÂбþ¤·¤Æ¤¤¤Þ¤»¤ó¡Ë

¡ù¤³¤ì°Ê²¼¤Î²èÁü¤Ï±ÜÍ÷¥½¥Õ¥È¥¤¥ó¥¹¥È¡¼¥ë¸å¤ÎÁàºîÀâÌÀ¤Ç¤¹
¡ÖNDP sign in¡×¤Î¥Ú¡¼¥¸¤Ø°Üư¤·¤Þ¤¹¡£(VS¤¬Í­¸ú¤Ê¥¹¥é¥¤¥É¤Ë¤Ï¡ØVS¤ò¸«¤ë¡Ù¤Ê¤É¤Îɽ¼¨¤¬¤¢¤ê¤Þ¤¹¡£¤½¤ì¤ò¤¯¤ê¤Ã¤¯¤¹¤ë¤ÈNDP sign in¤Î¥Ú¡¼¥¸¤Ë¹Ô¤­¤Þ¤¹¡£)Sign in as Guest¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

signinpage.png

Ž¢Browse Images Ž£¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

browseImagepage.png

¥µ¡¼¥Ð¼ýǼ¥Õ¥¡¥¤¥ë°ìÍ÷¤Ç¤¹SPS¥Õ¥¡¥¤¥ë¤òÁªÂò¥¯¥ê¥Ã¥¯¤ÇSPS¥¹¥é¥¤¥É°ìÍ÷¤¬¤Ç¤Þ¤¹¡£

Homepage.png

Virtual slide¤Î±ÜÍ÷¤¬½ªÎ»¤·¤¿¤é±¦¾å¤Î¥Ü¥¿¥ó¤Çsign out¤·¤Æ¤¯¤À¤µ¤¤


SPS¾ÉÎã¥ô¥¡¡¼¥Á¥ã¥ë¥¹¥é¥¤¥É¥Ç¡¼¥¿¥Ù¡¼¥¹²½¤Ø¤ÎÄó°Æ¤È¤ª´ê¤¤

ÀŲ¬ÉÂÍý°å²ñ²ñ°÷³Æ°Ì

ÀèÆü¤ÎSPS¤Ç¤Ï¿¿ô¤Î¾ÉÎã¤Ë¤Ä¤¤¤ÆÊÙ¶¯¤µ¤»¤Æ¤¤¤¿¤À¤­¤¢¤ê¤¬¤È¤¦¤´¤¶¤¤¤Þ¤·¤¿¡£ ËÜÆü¤ÏSPS¤Î¥¹¥é¥¤¥É¶¦Í­¤Ë¤Ä¤¤¤ÆÄó°Æ¤È¤ª´ê¤¤¤ò¤¤¤¿¤·¤¿¤¯¡¢Ï¢Íí¤µ¤»¤Æ¤¤¤¿¤À¤­¤Þ¤¹¡£

ºÇ¶á¡¢É;¾°åÂç¤ËÉ;¾¥Û¥È¥Ë¥¯¥¹¤Î¥ô¥¡¡¼¥Á¥ã¥ë¥¹¥é¥¤¥É¥·¥¹¥Æ¥à(°Ê²¼VSS)¤¬Æ³Æþ¤µ¤ì¤Þ¤·¤¿¡£¤³¤ì¤Ï¾Ë»Ò¥¹¥é¥¤¥É¤ÎɸËܤò¥Ç¥¸¥¿¥ë²èÁü²½¤·¤ÆÊݸ¤·ÉÕ°¤Îviewer¥½¥Õ¥È¤Ë¤è¤ê¥Ñ¥½¥³¥ó¥â¥Ë¥¿¤Ç¸¡¶À²Äǽ¤Ë¤¹¤ëÁõÃ֤Ǥ¹¡£¥ë¡¼¥ÚÁü¤«¤é¸÷¸²¤Î40ÇܤޤÇÄ̾ï¤Î¸²Èù¶À¤È½¿§¤Î¤Ê¤¤¥¯¥ª¥ê¥Æ¥£¤Ç±ÜÍ÷¤¬¤Ç¤­¤Þ¤¹¡£viewer¥½¥Õ¥È¤Ï̵ÎÁ¤ÇÇÛÉۤǤ­¤Þ¤¹¡£¡ÊAdobe¤Îacrobat¤ÎÊý¼°¡Ë ¤³¤ÎÁõÃÖ¤ò»È¤Ã¤Æ¡¢ÀèÆü¤Î215²óSPS¾ÉÎ㥹¥é¥¤¥ÉɸËܤò¥Ç¥¸¥¿¥ë²½¤·²ñ°÷³Æ°Ì¤ËÇÛÉÛ¤·¤¿¤¤¤È¹Í¤¨¤Þ¤¹¡£¤´»¿Æ±¤¤¤¿¤À¤±¤ëÊý¤Ï¾ÉÎã¤ÎHE¥¹¥é¥¤¥É¤ò£±Ëç벬°¸¤ËÆÏ¤±¤ÆÄº¤±¤Ê¤¤¤Ç¤·¤ç¤¦¤«¡£¸Ä¿Í¾ðÊó¤Ë¤Ä¤¤¤Æ¤ÏÉÂÍý³Ø²ñ¤Î»Ø¿Ë¤ò½å¼é¤·¤Þ¤¹¡£
Á÷ÉÕ¤¤¤¿¤À¤¤¤¿¥¹¥é¥¤¥É¤Ï¥¹¥­¥ã¥ó½ªÎ»¸å¤ËÊÖµÑÃפ·¤Þ¤¹¡£

¥¹¥é¥¤¥É¤Î¶¦Í­²½¤Ë¤Ï3¼ïÎà¤ÎÊýË¡¤ò¹Í¤¨¤Æ¤¤¤Þ¤¹¡£

  1. ¥µ¡¼¥Ð¤«¤é¤ÎVS¥Õ¥¡¥¤¥ë¥À¥¦¥ó¥í¡¼¥É¤¹¤ë
  2. ¥µ¡¼¥Ð¾å¤Î²èÁü¤ò¥¤¥ó¥¿¡¼¥Í¥Ã¥È¤«¤é±ÜÍ÷¤¹¤ë
  3. DVD¤Ë¾Æ¤¤¤ÆÇÛ¤ë

£±¡¥¤ÎÊý¼°¤Ë¤Ä¤¤¤Æ¤Ï²èÁü¥Õ¥¡¥¤¥ë¤Î¥Ç¡¼¥¿¤¬µðÂç¤Ê¤¿¤á¥µ¡¼¥Ð¤«¤éľÀÜ¥À¥¦¥ó¥í¡¼¥É¤¹¤ë¤ÈÉé²Ù¤¬¤«¤«¤ê¤¹¤®¤Þ¤¹¡£¤½¤Î¤¿¤áP2P(¥Ô¥¢¥Ä¡¼¥Ô¥¢)¥½¥Õ¥È¤ò»ÈÍѤ·¤Þ¤¹¡£P2P¥½¥Õ¥È¤ÏWinny¤Ç°­Ì¾¹â¤¯¡©¤Ê¤Ã¤Æ¤·¤Þ¤¤¤Þ¤·¤¿¤¬ËÜÍè¤ÏÂ礭¤Ê¥Õ¥¡¥¤¥ë¤Î¥Ç¡¼¥¿¤òÇÛÉÛ¤¹¤ë¤¿¤á¤ËÍ­ÍѤʥ½¥Õ¥È¤Ç¤¹¡£Linux¤ÎÀ¤³¦¤Ç¤ÏOS¤ÎÇÛÉÛ¤ËÄ̾ï»ÈÍѤµ¤ì¤Æ¤ª¤ê¹çË¡¤Ê¥Ç¡¼¥¿¤Î¤ß¥À¥¦¥ó¥í¡¼¥É¤¹¤ì¤Ð°ÂÁ´¤Ç¤¹¡£º£²ó¤Ï¥Õ¥ê¡¼¥½¥Õ¥È¤ÎbitTorrent¤ò»È¤¤¤Þ¤¹¡£ bitTorrent¤ÏµðÂç¤Ê¥Õ¥¡¥¤¥ë¤ò¹â®¤Ë¥À¥¦¥ó¥í¡¼¥É¤¹¤ë¤³¤È¤òÌÜŪ¤Ë³«È¯¤µ¤ì¤¿P2P¥¯¥é¥¤¥¢¥ó¥È¥½¥Õ¥È¡£ ¾¤Î¿¤¯¤ÎP2P¥Õ¥¡¥¤¥ë¶¦Í­¥½¥Õ¥È¥¦¥§¥¢¤È°Û¤Ê¤ê¡¢BitTorrent¤ÏÈóƿ̾¤ÎP2P¥Í¥Ã¥È¥ï¡¼¥¯¤Ç¤¹¡£ Èóƿ̾¤Î¤¿¤á°ãË¡¥Õ¥¡¥¤¥ë¶¦Í­¤Ê¤É¤Ø¤Î°­ÍѤòËɤ®¤Ä¤Ä¡¢¥¤¥ó¥¿¡¼¥Í¥Ã¥È¾å¤Î»ñ¸»¤òÍ­¸úÍøÍѤ·¤ÆµðÂç¤Ê¥¢¥×¥ê¥±¡¼¥·¥ç¥ó¤ä¥Þ¥ë¥Á¥á¥Ç¥£¥¢¥Õ¥¡¥¤¥ë¤ÎÇÛÉÕ¤¬²Äǽ¤Ç¤¹ ¥Õ¥ê¡¼¤Î¥½¥Õ¥È¤Ç¤ÏbitComet¤ÈAzreus¤¬Í­Ì¾¤Ç¤¹¡¥windows¤Ç¤ÏbitCommet¤¬Â¿ÍѤµ¤ì¤Æ¤¤¤ë¤è¤¦¤Ç¤¹

£²¡¥¤Ë¤Ä¤¤¤Æ¤Ï½ãÀµÉʤΥµ¡¼¥ÐÇÛÉÛ¥½¥Õ¥È»ÈÍÑÎÁ¤¬10Ëü±ß/·î¤È¹â²Á¤Ê¤¿¤áƳÆþ¤·¤Æ¤¤¤Þ¤»¤ó¡£¤³¤ì¤¬¤¢¤ì¤Ð¥¦¥¨¥Ã¥Ö¤«¤é±ÜÍ÷¤Ç¤­¤Þ¤¹¤¬¸½ºß¤Ï̵Íý¤Ç¤¹¡£º£±ÜÍ÷ÊýË¡¤Î¼Â¸³¤ò¤·¤Æ¤¤¤Þ¤¹¡£¤¦¤Þ¤¯¤¤¤±¤Ð¤ª¶â¤¬¤«¤«¤é¤º¤Ë¥¤¥ó¥¿¡¼¥Í¥Ã¥È¾å¤Ç±ÜÍ÷¤Ç¤­¤ë¤è¤¦¤Ë¤Ê¤ë¤«¤â¤·¤ì¤Þ¤»¤ó¡£±ÜÍ÷¤Ë¤ÏÀ©¸Â¤ò¤·¤ÆÉô³°¼Ô¤ÎÀܳ¤òÀ©¸Â¤·¤Æ¤¤¤Þ¤¹¡£

£³.°ì²ó¤Î¥Õ¥¡¥¤¥ë¥Ç¡¼¥¿¤ÏDVD1-2Ëç¤Ë¼ý¤Þ¤ë¤È»×¤¤¤Þ¤¹¡£DVDÂå¤È͹Á÷ÎÁ¤¬¤«¤«¤ê¤Þ¤¹¤¬ºÇ¤â¥ª¡¼¥½¥É¥Ã¥¯¥¹¤ÊÊýË¡¤Ç¤¹¡£

°ÊÁ°¤è¤ê¡¢SPS¤Îµ®½Å¤Ê¾ÉÎã¤Î¥¹¥é¥¤¥É¤ò¶¦Í­¤·¤Æ¤¤¤Ä¤Ç¤â¸«ÊÖ¤·¤¬¤Ç¤­¤Ê¤¤¤«¤È¹Í¤¨¤Æ¤ª¤ê¤Þ¤·¤¿¡£ÃæÉô¸ò¸«²ñ¤â¤½¤¦¤Ç¤¹¤¬²¿Ëç¤â¥¹¥é¥¤¥É¤òºî¤ë¤Î¤ÏÂçÊѤǤ¹¡£VSS¤Ê¤é¿ÇÃǤËÍѤ¤¤¿¥ª¥ê¥¸¥Ê¥ë¤ÎHE¥¹¥é¥¤¥É¤ò°ìËç¤ò¥Ç¥¸¥¿¥ë²½¤·¤Æ¤ª¤±¤ÐÁ´°÷¤Ç¶¦Í­²Äǽ¤Ë¤Ê¤ê¡¢Îô²½¤»¤º¤¤¤Ä¤Ç¤â±ÜÍ÷¤¬¤Ç¤­¤ë¤è¤¦¤Ë¤Ê¤ê¤Þ¤¹¡£ °Ê¾åѨ±Û¤Ç¤Ï¤¢¤ê¤Þ¤¹¤¬¡¢µ¡´ï¤Î³«È¯¤Ë¿¾¯´Ø¤ï¤Ã¤¿±ï¤ÇSPS¤Î¥ô¥¡¡¼¥Á¥ã¥ë¥¹¥é¥¤¥É¶¦Í­²½¤Ë¤Ä¤¤¤ÆÄ󰯤µ¤»¤ÆÄº¤­¤Þ¤·¤¿¡£SPS¤ò¥¹¥é¥¤¥É¶¦Í­¤ÎÀ®¸ùÎã¤Ë¤·¤¿¤¤¤È¶¯¤¯´ê¤Ã¤Æ¤ª¤ê¤Þ¤¹¡£ Wikipathologica-- ¤ß¤ó¤Ê¤Çºî¤ëÉÂÍý¥¢¥È¥é¥¹¤â¤´Í÷²¼¤µ¤¤¡£

ÈØÅÄ»ÔΩÁí¹çɱ¡¡¡Ã«²¬¡¡½ñɧ¡¡É;¾°åÂçÉÂÍý³ØÂè°ì¹ÖºÂ¡¡¿ú¼¡¡½Õɧ

mail to wikipathologica@gmail.com


źÉÕ¥Õ¥¡¥¤¥ë: fileHomepage.png 1381·ï [¾ÜºÙ] filesigninpage.png 4242·ï [¾ÜºÙ] filebrowseImagepage.png 1431·ï [¾ÜºÙ]

¥È¥Ã¥×   º¹Ê¬ ¥Ð¥Ã¥¯¥¢¥Ã¥× ¥ê¥í¡¼¥É   °ìÍ÷ ñ¸ì¸¡º÷ ºÇ½ª¹¹¿·   ¥Ø¥ë¥×   ºÇ½ª¹¹¿·¤ÎRSS
Last-modified: 2020-10-04 (Æü) 13:54:34 (107d)